Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

M
Ma Q.	-	Heparinase I digestion of tinzaparin: a novel approach to neutralize the anti-coagulant and potential hemorrhagic effects of low molecular weight heparin
	-	Fibrinopeptide-A generation inhibition by anti-Xa drugs and its correlation with activated clotting time
Ma T.	-	New diagnostic guideline for coronary heart disease in old people
Ma D.	-	Detection of procoagulants with a more reliable nonactivated clotting test
Ma D. D. F.	-	Abciximab therapy post elective coronary artery stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin and platelet-monocyte aggregates
Ma Q.	-	Pharmacodynamic profile of Intimatan as an antithrombotic agent for venous thrombosis
Ma D. D. F.	-	A single-center prospective study of clinical and genetic thrombophilic risk factors for deep venous thrombosis (DVT) in 510 patients undergoing elective lower limb surgery
Ma Q.	-	Activated clotting time guided dosage optimization of a low molecular weight heparin (tinzaparin) for surgical and interventional indications
	-	Oral antithrombin agents comprise the regulatory functions of thrombin
	-	Molecular-weight dependence on the inhibition of procarboxypeptidase U by heparin and a polydeoxyribonucleotide derived antithrombotic agent (Defibrotide)
	-	Non-coagulant variants of thrombin are capable of activating procarboxypeptidase U
	-	Nitric oxide levels are up-regulated in patients with malignancy associated hypercoagulable state
Ma Q.	-	Heparin derived oligosaccharides are capable of passing through the blood brain barrier: experimental evidence in a rat model
Ma T.	-	The roles of serum insulin-like growth factor and binding protein, human growth hormone, matrix metalloproteinases and interleukin-10 in coronary heart disease to heart failure
Ma Q.	-	Considerations in the standardization of the functional and immunologic assays for human procarboxypeptidase U. Diagnostic implications
Ma D.	-	An evaluation of preoperative hemostatic variables as risk factors for deep venous thrombosis after elective lower limb arthroplasty
	-	Procoagulant phospholipid in blood normally associates mainly with cells or aggregates larger than microparticles or platelets
Ma Q.	-	Polypharmacologic actions of low-molecular-weight heparins: lessons from clinical trials
Ma Q.	-	Pharmacodynamics and pharmacokinetics of anti-Xa potency adjusted heparin derived oligosaccharides in nonhuman primates: implications in dosage optimization
Maakaroun A.	-	Changes in the platelet count (PC) after cardiopulmonary bypass (CPB) can efficiently predict the development of pathogenic heparin- dependent antibodies (Abs)
Maakaroun A.	-	G20210A prothrombin gene mutation appears as the most important inherited prothrombotic risk factor in ‘idiopathic’ portal vein thrombosis
	-	Inherited risk factors are different in pregnant and nonpregnant women with venous thromboembolism
Maakaroun A.	-	Frequency of platelet glycoproteins alpha2807T and GPIbalpha Kozak polymorphisms in central retinal vein occlusion
Maassen C.	-	The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma
Maayan A.	-	Thrombophilia does not increase the risk for neonatal complications in preterm infants
Mac Gillavry M.	-	Levels of endothelial activation markers, D-dimer fragments and pro-inflammatory cytokines and sickle cell disease severity
Mac gillavry M. R.	-	Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Mac Gillavry M. R.	-	Physicians' interpretation of ventilation-perfusion lung scans
Mac Gillavry M.	-	Elevated steady state serum sVCAM-1 levels occur from an early age in sickle cell patients, but are not related to vasoocclusive crises and acute chest syndrome frequency
	-	Reduced protein C and S activity and sickle cell disease severity
Mac Gillavry M. R.	-	Effect of pravastatin on plasma markers of coagulation and inflammation in type 2 diabetes
	-	Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism
Macarie I.	-	Use of recombinant activated factor VII (NovoSeven) in patients with liver cirrhosis
Macartney N.	-	Population-based study of acquired hemophilia A
Macartney C.	-	A transient factor V inhibitor associated with vasculitis
Maccallum P.	-	Multivariate investigation of determinants of oral anti-coagulant stability
Maccallum P. K.	-	Associations of hemostatic variables with changes in anthropometric measures and metabolic variables in the morbidly obese
Maccallum P. K.	-	Effect of bezafibrate on plasma homocysteine in men with lower extremity arterial disease
MacCallum P. K.	-	The predictive value of C-reactive protein (CRP) for myocardial infarction may be affected by aspirin therapy in men with lower extremity arterial disease
Maccallum P. K.	-	C-reactive protein (CRP) may predict death from cancer in men with lower extremity arterial disease
Macchi L.	-	Recurrent thrombosis in a young patient with a left-sided inferior vena cava and factor V Leiden and prothrombin 20210A
	-	Three abnormal patterns for inversion breaking intron 1 of the FVIII gene
MacDonald T.	-	Aspirin for CV prevention: NSAID interactions: adverse effects and costs
Macdougall A.	-	Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement
Macgillavry M. R.	-	Effect of hyperhomocysteinemia on coagulation activation and endothelial cell activation
Macgillivray R. T. A.	-	Severe factor VII deficiency caused by a new point mutation combined with a previously undetected gene deletion
	-	Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Macgregor D.	-	Studies to define the clinical impact of ‘mild’ hemophilia A in a large kindred in Newfoundland and Labrador
Macgregor D. L.	-	Low molecular weight heparin therapy in neonatal cerebral sinovenous thrombosis: a consecutive cohort study
Macgregor D.	-	Frequency and predictors of vaso-occlusive strokes associated with cardiac surgery in infants and children with congenital heart disease
Macgregor I. R.	-	Removal of a BSE-derived agent by ion exchange chromatography used in the manufacture of a high purity factor VIII concentrate
Mach F.	-	Effects of statins on adhesion molecules expression in endothelial cells
Machiah D.	-	Functional re-sequencing of the factor VIII (f-VIII) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-VIII activity levels in the Gait Project
Machin S. J.	-	A novel r-polypeptide, kunitz-type inhibitor with high specificity for plasma kallikrein and potential for therapeutic use
	-	A study of 10 rapid d-dimer tests for the exclusion of acute venous thromboembolism
Machin M.	-	Lagrangian modeling of platelet adhesion and its application to experimental data
Machin S. J.	-	Direct association of HCII and red blood cells
	-	A proposed ISTH revised classification for the anti-phospholipid syndrome
Machin S.	-	Activated protein C resistance (APCR) and combined oral contraceptives: acquired APCR is more pronounced in women receiving desogestrel containing COCs than those containing levonorgestrel and is associated with low protein S levels
Machin S. J.	-	A humanized monoclonal antibody against vWF A1 domain inhibits vWF:RiCof activity and platelet adhesion in human volunteers
	-	The mechanism of platelet activation by recombinant factor VIIa in normal subjects and inherited hemostatic disorders – a whole blood, flow cytometric study
	-	Venous thromboembolism (VTE) associated with the management of acute thrombotic thrombocytopenic purpura (TTP)
	-	Whole blood thromboelastography and platelet function studies with DX-88, a Kunitz-type inhibitor of kallikrein
	-	The effect of pathogen inactivation treatment processes on VWF cleaving protease, VWF:Ag and protein S levels in blood components used in therapeutic plasma exchange for thrombotic thrombocytopenic purpura
Machin S.	-	Expression of prion protein (PrPC) in the megakaryocyte lineage
Machin S. J.	-	Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and antibeta2GPI antibodies
Machovich R.	-	Thrombin receptors on the cells of the blood–brain barrier
Macik B. G.	-	Activated Recombinant Factor VII (rFVIIa) for the reversal of hepatic and warfarin induced coagulopathy prior to invasive procedures
Mackensen V. S.	-	Validation of the first hemophilia-specific quality of life questionnaire for children and adolescents (Hemo-QoL)
Mackie I. J.	-	Direct association of HCII and red blood cells
	-	Activated protein C resistance (APCR) and combined oral contraceptives: acquired APCR is more pronounced in women receiving desogestrel containing COCs than those containing levonorgestrel and is associated with low protein S levels
	-	A proposed ISTH revised classification for the anti-phospholipid syndrome
	-	A study of 10 rapid d-dimer tests for the exclusion of acute venous thromboembolism
	-	A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique
Mackie I.	-	A novel r-polypeptide, kunitz-type inhibitor with high specificity for plasma kallikrein and potential for therapeutic use
Mackie I. J.	-	A humanized monoclonal antibody against vWF A1 domain inhibits vWF:RiCof activity and platelet adhesion in human volunteers
Mackie I. J.	-	The mechanism of platelet activation by recombinant factor VIIa in normal subjects and inherited hemostatic disorders – a whole blood, flow cytometric study
Mackie F.	-	Recombinant factor VIIa used to control massive hemorrhage during renal transplantation surgery; vascular graft remained patent
Mackie I. J.	-	Whole blood thromboelastography and platelet function studies with DX-88, a Kunitz-type inhibitor of kallikrein
	-	Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and antibeta2GPI antibodies
Mackie I.	-	Expression of prion protein (PrPC) in the megakaryocyte lineage
	-	Serial changes in hemostasis following subarachnoid hemorrhage
Mackie I. J.	-	The effect of pathogen inactivation treatment processes on VWF cleaving protease, VWF:Ag and protein S levels in blood components used in therapeutic plasma exchange for thrombotic thrombocytopenic purpura
Mackinnon B.	-	Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
	-	Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Mackman N.	-	Role of the tissue factor-thrombin pathway in endotoxemia
Mackman N.	-	Tissue factor: lessons from knock-outs, knock-ins and transgenic mouse models
Mackman N.	-	Role of cardiac myocyte tissue factor in hemostasis in the heart
Mackway-Jones K.	-	Comparison of the clinical utility of two D-dimer tests (IL Test and Simpify) in the diagnosis of pulmonary embolism
Maclachlan R.	-	A new von Willebrand factor (VWF) online mutation and polymorphism database created on behalf of the ISTH VWF scientific and standardization committee (http://www.sheffield.ac.uk/vwf)
Maclean P. E.	-	Impact of knowledge of a positive family history on the clinical presentation of hemophilia
	-	Incidence and risk factors for factor VIII antibodies in mild hemophilia A
Macleod D.	-	A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer
MacMahon M.	-	A randomized, double-blind, placebo-controlled study of the safety and pharmacokinetics of a single dose of recombinant Factor XIII in healthy volunteers
Macnee W.	-	Procoagulant changes in human macrophages induced by environmental microparticles [PM₁₀]: a possible pathogenetic mechanism in cardiovascular disease
Maderna P.	-	Platelet-associated Tissue Factor: modulation of cell surface expression by platelet agonists
Madhani M.	-	Multivariate investigation of determinants of oral anti-coagulant stability
Madlener K.	-	Induction of monocytic tissue factor (TF) expression: an additional mechanism of action of desmopressine acetate (DDAVP)
	-	Gene expression analysis in platelets: use of a PCR-based RNA amplification technique for generating suitable amounts of cDNA
	-	Anti-endothelial cell antibodies (AECA): cDNA-based antigen screening
Madlener K.	-	Use of aprotinin as an antidote in activated protein C related bleeding
Madoiwa S.	-	Neonatal injection of human factor VIII induces immune tolerance in murine hemophilia A
Madonna R.	-	Insulin enhances vascular cell adhesion molecule (VCAM-1) expression in human cultured endothelial cells – a link to the pathogenesis of accelerated atherosclerosis in diabetes
	-	Inhibition of 3-Hydroxy-3-methylglutaryl coenzyme-A reductase attenuates expression of inducible nitric oxide synthase in cardiac myoblasts – Possible link to direct myocardial protection during ischemia-reperfusion
Madri J.	-	Matrix, protease and angiogenesis
Maehara Y. M.	-	Recombinant sendai virus-mediated intramuscular gene transfer of FGF-2 restores collateral blood perfusion of chronically ischemic rabbit hind limb, and inhibits neointimal hyperplasia of autologous femoral vein grafts
Maehara Y.	-	Platelet-derived growth factor receptor-alpha signaling is required for therapeutic angiogenesis induced by fibroblast growth factor-2
Maffei F. H. A.	-	A 23-bp insertion in the EPCR gene and the risk of venous thrombosis
Maffei F. H. A.	-	Prophylaxis of deep vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin
Maffei F. H. A.	-	Factor XIII (FXIII) Val34Leu, His95Arg and G30899A polymorphisms and the risk of deep venous thrombosis
	-	A transcobalamin gene polymorphism and the risk of deep venous thrombosis
Maffei F. H. A.	-	Anti-thrombotic effect of combination of low molecular weight heparin with low doses of unfractionated heparin in experimental venous thrombosis
Maffei F. H.	-	Efficacy and safety of once-daily Enoxaparin given in the outpatient setting compared with in-hospital unfractionated heparin for treatment of proximal lower limb deep-vein thrombosis
Magari Y.	-	A novel ELISA method for soluble fibrinogen and fibronectin complexes (FG–FN) in normal adult's and DIS patient's plasma
Magdelaine A.	-	Inherited thrombophilia is not associated with an increased risk of intrauterine fetal death
Magdeleijns E. J. P.	-	Venous thrombosis and APC resistance during hormone treatment in male-to-female transsexuals
Magdeleyns E. J. P.	-	Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool
Magier D.	-	Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study
Magnova O.	-	rFVIIa NovoSeven^®– Hemostatic agent not only for hemophiliacs
Magnusson R.	-	Application of a novel polypeptide affinity ligand for purification of recombinant FVIII
Magro F.	-	A different view on the inflammatory bowel disease – the role of adhesion molecules and angiogenic growth factors
Maguire P. B.	-	Platelet proteomics
Maguire N.	-	Reduction in stillbirth and IUGR with aspirin +/- low molecular weight heparin treatment in pregnancy
Maguire P. B.	-	Proteomic analysis of proteins secreted by platelets
Mah A. F.	-	Timing of initial administration of prophylaxis against deep vein thrombosis in patients following hip or knee surgery
	-	A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months vs. intravenous heparin followed by warfarin sodium in patients with current cancer
	-	Does rebound exist? A comparison of venous thromboembolic event rates in the post-treatment period for patients randomized to long-term low-molecular-weight heparin vs. warfarin sodium
	-	A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by Warfarin Sodium
Mahan D.	-	The Rapidpoint™ ENOX point-of-care test has strong correlation with anti-Xa levels for detecting the anti-coagulant effects of enoxaparin
Mahaut-Smith M.	-	Quantification of the platelet-generating demarcation membrane system in living megakaryocytes
Mahdi F.	-	Recombinant prolylcarboxypeptidase activates plasma prekallikrein
Mahdi F.	-	Mapping the interaction between uPAR and high molecular weight kininogen
Mahé I.	-	d-dimer levels: a prognostic value in patients with chronic atrial fibrillation
Mahé I.	-	A comparative pharmacodynamic study of anti-Xa activity to evaluate the accumulation effect of Tinzaparin and Enoxaparin given at prophylactic dose over 8 days in elderly patients with impaired renal function
Mahé I.	-	Oral anti-coagulation in elderly patients in clinical practice: 187 patients
	-	Early prediction of the sensitivity of warfarin in elderly patients by the fall in factor VII
Mahmood A.	-	Hypercoagulability in inflammatory bowel disease
Mahnel R.	-	Using a modified thrombin generation assay for potency assessment of B-domain deleted recombinant factor VIII (ReFacto^®)
	-	Thrombin generation in platelet-rich plasma (PRP) is enhanced in patients with metabolic syndrome
Maillard C.	-	Plasminogen activator inhibitor PAI-1 as a regulator of urokinase in angiogenesis
Mainusch K.	-	Comparative expression of recombinant wildtype and mutant von Willebrand factor cleaving protease ADAMTS13
Mainwaring J.	-	Peri-operative bleeding in patients with Pseudomyxoma peritonei appears to relate to trauma induced hypofibrinogenemia
	-	Bleeding in patients with factor XII deficiency may relate to concomitant platelet function disorders if von Willebrand's disease is excluded
Mainwaring C. J.	-	Effect of warfarin anticoagulants on elements of the tissue factor pathway and other procoagulant markers
	-	TAFI antigen levels in local hemophilia A and vWD population
	-	Hypercoagulability in inflammatory bowel disease
Mairuhu A. T. A.	-	Endothelial cell and monocyte-derived microparticles in severe dengue virus infections
	-	Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Majumder R.	-	Water soluble phosphatidylserine (C6PS) induces bovine factor Xa structural change and dimerization; do factor Xa dimers have a physiological role?
	-	Efficient human thrombin generation requires molecular phosphatidylserine and not a membrane surface
	-	A phosphatidylserine binding site distinct from the C2 domain membrane attachment site regulates the assembly and activity of the human prothrombinase
Makatsaria A. D.	-	Differential diagnostics of abnormal uterine bleeding
Makatsaria A.	-	A case of pregnancy and labor management in patient with recurrent thromboses and multigenic thrombophilia
	-	Low molecular heparin in prophylaxis of thrombohamorragic complications after caesarean delivery in patients with cardiologic deseases
	-	Prophylaxis of main obstetric complications in pregnant women with anti-phospholipid syndrome and genetic forms of thrombophilia
Makatsaria A. D.	-	The role of herpetic infections in genesis of endothelial damage in pregnant women with fetal loss syndrome
Makatsaria A.	-	A case of catastrophic anti-phospholipid syndrome in pregnant woman with eclampsia
Makek G.	-	Compression ultrasound in diagnosis of asymptomatic deep venous thrombosis
Makris P. E.	-	High frequency of factor V Leiden and prothrombin G20210A mutations in Greek hemophiliacs
Makris M.	-	Basal Fibrinogen and FVIII:C Concentrations are not Associated with Polymorphisms in the Interleukin-1 Gene Cluster
Makris P. E.	-	Synthetic tripeptides with specific inhibitory action against Gp-Ib glycoprotein
Makris M.	-	Transport of blood samples through a pneumatic tube system causes loss of platelet function
Makris P.	-	Factor VIII inhibitor in a patient with multiple sclerosis and interferon regimen
Makris M.	-	Comparison of cytotrophoblast gene expressed in normal and pre-eclamptic placenta
	-	SSC classification of hemophilia A: is it achievable? A UKNEQAS supplementary exercise
	-	Profile of mutations in a UK hemophilia A patient population
Makris P. E.	-	Congenital defect of inferior vena cava and thrombophilia Leiden
Makris M.	-	The use of two plasma derived Factor VIII concentrates in type 2 A von Willebrand's disease (VWD)
	-	The effect of two novel plastic citrate tubes (BD Vacutainer Plus): Results in normal subjects and subjects undergoing Unfractionated heparin therapy
	-	ROTEG thromboelastography: sample stability and results in warfarinized and heparinized patients
	-	Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
	-	Marked variation in d-Dimer concentration as determined by four different assays
Makris P.	-	Acute ischemic strokes: LMWHs or aspirin administration and laboratory monitoring
Makris P. E.	-	Treatment of DIC: the role of PC
Makris M.	-	Characterization of a new therapeutic recombinant human anti-thrombin concentrate
	-	Characterization of mutations in a cohort of type 2 von Willebrand disease patients
Makris P. E.	-	Thrombophilic tendency in patients with chronic renal disease submitted to regular dialysis
	-	Sticky platelet syndrome
Makris P.	-	Acute ischemic strokes: LMWHs or aspirin administration and laboratory follow-up
Makris M.	-	A comparative study of new generation blood sampling tubes for thrombophilia investigations
	-	A novel R2464C candidate von Willebrand factor mutation in families with von Willebrand disease
Makropoulos D.	-	The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Maksimenko A.	-	Combined anti-thrombotic protection of vascular wall with bienzyme superoxide dismutase–chondroitin sulphate–catalase conjugate in vivo
Maksimovic D.	-	Thrombosis risk factor assessment in surgical patients: compliance with chest consensus guidelines
	-	Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement
	-	Report from the studies on prevention: Extended travel
	-	Thrombosis prophylaxis following total hip replacement
Malan E.	-	A prospective multicentre study assessing the random error rates of routine coagulation tests
Malato A.	-	Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
	-	Chemotherapy-induced activation of hemostasis: the role of d-dimer
	-	Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
Malcovati M.	-	Congenital afibrinogenemia, identification of four novel homozygous mutations in the fibrinogen gene cluster: three point mutations and a 15-kb deletion
	-	Allelic heterogeneity of severe factor V deficiency: doubling of the mutational spectrum of the factor V gene, and expression of the identified missense mutations
Male C.	-	Central venous line-related thrombotic events in children: association with duration of line placement, type, size, and location
Malefora A.	-	Increased platelet activation in hyperhomocysteinemic patients
Malinin A.	-	Effects of clopidogrel-aspirin combination vs. aspirin alone on platelet aggregation and major receptor expression in patients with heart failure. For the plavix use for treatment of congestive heart failure (PLUTO-CHF) trial
Malinin A. I.	-	Platelet inhibition by valsartan and valeryl 4-hydroxy valsartan: a possible missing link to explain benefits of angiotensin II receptor blockers in patients after acute vascular events
Malinowska I.	-	Immune tolerance induction in the treatment of children with haemophilia A complicated by factor VIII inhibitor
Malizos K. N.	-	Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
	-	Is the G455A polymorphism of the fibrinogen beta gene associated with osteonecrosis? A preliminary report
Mallett T. C.	-	aIIbb3 integrin activation mechanisms – switchblade or scissors?
	-	Integrin clustering mechanisms explored with a soluble aIIbb3 ectodomain construct
Mallory S.	-	Patients receiving long-term warfarin therapy prefer INR testing with capillary fingerstick over venous blood testing
Malvido-Miranda E.	-	Lipoprotein (a) polymorphisms in Mexican-Amerindian populations
Maly J.	-	Haemostyptics agents and blood platelet functions
	-	Risk of venous thromboembolism during pregnancy and puerperium in women with homozygous form of F V Leiden
Malyszko J.	-	Effects of different heparins on thrombin-activatable fibrinolysis Inhibitor-TAFI in hemodialyzed patients
	-	Soluble CD-146 and other markers of endothelial function are elevated in peritoneally dialyzed and chronic renal failure patients
Malyszko J. S.	-	Soluble CD-146 and other markers of endothelial function are elevated in peritoneally dialyzed and chronic renal failure patients
Malyszko J.	-	A prospective analysis of hemostasis in systemic inflammatory response syndrome (SIRS) with acute renal failure
Malyszko J. S.	-	A prospective analysis of hemostasis in systemic inflammatory response syndrome (SIRS) with acute renal failure
Malyszko J.	-	Different pattern of hemostatic abnormalities in infectious and noninfectious systemic inflammatory response syndrome (SIRS)
Malyszko J.	-	Different pattern of hemostatic abnormalities in infectious and noninfectious systemic inflammatory response syndrome (SIRS)
Manara R.	-	Association between fibrinogen levels and fibrinogen G-455 A polymorphism and preclinical atherosclerosis in the general population
Manarini S.	-	SRC-dependent signaling is a key step in the process of autoregulation of Mac-1 adhesive function in human PMN
	-	Injection of the inflammatory peptide fMLP in the rabbit induces transient myocardial ischemia: role of thromboxane A2
	-	Are daily doses of 80 and 160 mg of aspirin bioequivalent? A pharmacokinetic and pharmacodynamic approach
	-	Beta-2 integrin adhesion triggered by E-selectin in human PMN: role of SRC kinases and of an unidentified receptor
Manchanda N.	-	Plasminogen activator inhibitor reversibly inhibits cell-surface single-chain but not two-chain urokinase associated plasminogen activation
Manco-Johnson M.	-	Recombinant activated protein C (drotrecogin) is effective for purpura fulminans secondary to severe genetic protein C deficiency
Manco-Johnson M.	-	Lipoprotein A contributes to genetic risk for Venous Thrombosis and Arterial Stroke in U.S. Children
Manco-Johnson M.	-	Low-molecular-weight heparin dose requirements are age-related through childhood
Manco-Johnson M. J.	-	Factor VIII pharmacokinetics in young boys with hemophilia: novel measures for prophylaxis dosing
Manco-Johnson M.	-	Successful antithrombotic therapy employing intravenous bolus low molecular weight heparin in an extremely preterm infant
Mandell L.	-	Novel factor V mutations in three separate families resulting in factor V deficiency and bleeding
Mandrioli R.	-	Diagnosis of deep vein thrombosis in hospitalized elderly patients: poor discriminant value of clinical pretest probability unless integrated by d-dimer assay
Manduteanu I.	-	Effects of enoxaparin on high glucose induced activation of human endothelial cells
Manfredi E.	-	Determinants of delayed thrombus regression after deep vein thrombosis of the lower limbs: a prospective cohort study
	-	Early developments of the post-thrombotic syndrome in overweight and obese patients
	-	Weight changes after acute deep venous throbosis: a prospective observational study
Manganello J.	-	The platelet ADP receptor P2Y₁₂ is a critical player on the pathway of aIIbb3 activation by multiple agonists
Mangin P.	-	Evidence for a PLCg2-independent alpha2beta1-triggered signalling pathway contributing to platelet aggregation in response to collagen
	-	PLC g-dependent GPIb signaling following platelet adhesion to von Willebrand factor through a pathway distinct from FcR g chain and FcgRIIA
Mangos H. M.	-	Analysis of adult patients with von Willebrand disorder in South Australia
Manithody C.	-	Role of basic residues of proexosite 1 on prothrombin in the prothrombinase complex
Mann K. G.	-	Phenotypic thrombin generation: a composite view
	-	How factor VIIa works in hemophilia
Mann K. G.	-	What is all that thrombin for?
Mann K. G.	-	Systemic enzymatic activity in blood?
Mannami T.	-	Assessment of diagnostic procedures, ratio method and posterior probability method, for protein C deficiency using protein C and antithrombin activities
Mannhalter C.	-	Platelet glycoprotein mRNAs are expressed in megakaryocytes and platelet like cells and are regulated during differentiation
	-	Impact of platelet glycoprotein Ibalpha Kozak polymorphism on risk of ischemic cerebrovascular events
Mannhalter CH.	-	Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal disease
	-	A microsatellite polymorphism in the Heme Oxygenase – 1 gene promoter is associated with increased serum bilirubin and HDl levels but not with a decreased risk for coronary artery disease
Manning S. L.	-	The factor V Leiden mutation results in the in vivo loss of a critical FV anticoagulant function
	-	A sensitized ENU mutagenesis screen for dominant genetic modifiers of thrombosis in the factor V Leiden mouse
Manning A.	-	Treatment of patients with a history of heparin-induced thrombocytopenia (HIT type II) and of anti-lepirudin antibodies with argatroban or lepirudin
Mannini L.	-	TAFI plasma levels are not increased in ischemic heart disease patients admitted to a coronary care unit
Mannini L.	-	Increased lipoprotein(a) levels as an independent risk factor for idiopathic and recurrent venous thrombosis
	-	Rate of adverse events during OAT in patients with mechanical prosthetic heart valves replacement
Manno C. S.	-	A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Manns J. M.	-	Connective tissue growth factor (CTGF) expression in synovial lining is down regulated by residues D793-P824 derived from thrombospondin-1 type-3 repeats (TSP1) in an experimental animal model of rheumatoid arthritis
Manns J.	-	Regulation of connective tissue growth factor (CTGF) in synovial lining and modulation of the disease course of acute arthritis in an experimental model of rheumatoid arthritis by residues D793-P824 derived from thrombospondin-1-type 3 repeats
Mannucci P. M.	-	High risk of cerebral-vein thrombosis in patients with hyperhomocysteinemia
	-	Risk for recurrent venous thromboembolism among patients with severe inherited thrombophilia
	-	Standardization of activated protein C resistance testing: effect of residual platelets in frozen plasmas assessed with commercial and home made methods
	-	Arterio-venous fistula as permanent access for home treatment in children with hemophilia: long-term safety and feasibility
	-	Treatment of patients with VWD requiring elective surgery with a pasteurized von Willebrand Factor/FVIII concentrate (Haemate^®P) – the use of a PK-guided approach
	-	In vivo recovery, efficacy and safety of solvent/detergent treated plasma in patients with rare inherited bleeding disorders
	-	Lack of association between the annexin V gene -1C®T polymorphism and acute myocardial infarction in 150 young Italian women
	-	Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction
	-	Inherited thrombophilia and hyperhomocysteinemia in upper limb deep vein thrombosis
	-	A naturally homozygous deletion mutation of LYS9 or LYS10 in the A-chain of alpha-thrombin reduces the catalytic efficiency of the enzyme
	-	Functional characterization of a naturally occurring homozygous Gly25Ser mutation in thrombin B chain
	-	A 3' untranslated region (3' UTR) variation on the factor VII (FVII) gene changes completely the phenotype due to the Arg277Cys mutation in a patient with Type I FVII deficiency
Mannucci P.M.	-	Analysis of the molecular mechanism of factor VII (FVII) deficiency caused by IVS2 + 1 donor splice sites mutation by ‘Exon Trapping System’ technique
Mannucci P. M.	-	Congenital afibrinogenemia, identification of four novel homozygous mutations in the fibrinogen gene cluster: three point mutations and a 15-kb deletion
	-	Embryo implantation after assisted reproductive procedures and maternal thrombophilia
	-	A study of 130 Italian patients on anti-coagulant treatment: how variant alleles of gene CYP2C9 influence requirement dose of warfarin during the induction period of treatment
Mannucci P. P.	-	Analysis of 100 Iranian patients with factor XIII (sub unit A) deficiency
Mannucci P. M.	-	The three I hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH
Mannucci P. M.	-	Hemophilia: treatment options in the twenty-first century
Mannucci P. M.	-	In vitro expression study of two naturally occurring mutations (D141Y and C275S) of the von Willebrand factor (VWF) proeptide that result in defective multimerization and secretion
	-	Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 von Willebrand factor cleaving protease)
	-	Allelic heterogeneity of severe factor V deficiency: doubling of the mutational spectrum of the factor V gene, and expression of the identified missense mutations
	-	Impact of prenatal/perinatal events and early FVIII replacement on inhibitor risk in children with severe hemophilia
	-	In vitro expression study of four single nucleotide polymorphisms in the ADAMTS13 gene
Manolio T. A.	-	C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study (CHS)
Manoni M.	-	Cytokine gene expression and production in human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives
Manotti C.	-	An alternative model for management of oral anticoagulant therapy: role of general practitioners with support of a computerized system and a portable coagulometer
Manotti C.	-	Guidelines on management of nontherapeutic INRs: are really easy to apply in daily practice?
	-	Inferior vena cava filters: personal experience on 322 devices, with regard also to medical treatment during long-term follow-up
Manousakis E.	-	Obesity and coagulation. Is there any correlation?
	-	Is there an hypercoagulable state after treadmill exercise in patients with atrial fibrillation?
	-	Inflammatory factors in patients with acute coronary syndromes. Is there any fluctuation with smoking or cholesterol levels?
	-	Smoking and abnormalities of coagulation-fibrinolysis in patients with coronary heart disease
Mansbach C. M.	-	Glycosyl Phosphatidylinositol (GPI)-anchored protein(s) are required for cell surface expression of tissue factor pathway inhibitor (TFPI)
Mansfield M. W.	-	P-selectin polymorphisms: their relationship to soluble P-selectin levels and cardiovascular risk
Manso M.	-	Prospective study of the risk factors for the development of post–thrombotic syndrome after proximal deep vein thrombosis
Mansoor M.	-	Elevated concentrations of nitrate in plasma from smokers
Mansoor M. A.	-	Changes in homocysteine and lipid peroxidation by n-3 polyunsaturated fatty acids (PUFAs) administered after an acute myocardial infarction
Mansoor M.	-	Prevalence of hyperhomocysteinemia among aluminum industry workers
Mansour A.	-	Elevated Serum Nerve Growth Factor (NGF) levels in patients with acute leukemia and lymphoma especially with CNS involvement
Mansour H.	-	Oral anticoagulation telemedicine management system: the MC-SAT project
Mansouri Taleghani B.	-	Splenectomy in relapsing and plasma-refractory thrombotic thrombocytopenic purpura
	-	Observations on immunoadsorption (IA) as an auxiliary therapy for acquired thrombotic thrombocytopenic purpura (TTP)
Manta R.	-	Homocysteine plasma levels in primary biliary cirrhosis (PBC)
Mantilla-Capacho J. M.	-	Clinical manifestation of severe hemophilia B ameliorated by Prothrombin 20210A
Mantovani L. G.	-	Conjoint analysis: a new technique to quantify individual's preferences, to develop outcome measures and to determine optimal treatment patterns in hemophilia
Manur M.	-	Effects of proteasome inhibitors on alpha-granule secretion and microparticle formation during thrombin-induced platelet activation
Manzato F.	-	Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis
Manzo A.	-	The strong incidence of acquired and inherited thrombophilia in recurrent first trimester fetal loss
Mao G.	-	Characterization of 5'-upstream region of human phospholipase C-beta2 gene in megakaryocytic cell line
Maquoi E.	-	Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice
Marazzi A.	-	Preconceptional and gestational enoxaparin regimes adjusted to fertility program to prevent preclinical, embryonic and fetal loss in women with Recurrent Pregnancy Loss (RPL) and thrombophilia
Marbet G. A.	-	VCAM-1/VLA-4 up-regulation as a perpetuation loop in patients with chronic graft vs. host disease?
Marcato S.	-	Type Vicenza Arg1205His mutation alone induces reduction in the level and survival of von Willebrand factor
Marcato C.	-	Inferior vena cava filters: personal experience on 322 devices, with regard also to medical treatment during long-term follow-up
Marche P.	-	Evidence for extracellular signal-regulated kinase 1/2 activation by thrombin that is independent on epidermal growth factor receptor transactivation in vascular smooth muscle cells
Marchese P.	-	The P2X1 receptor for ATP plays an essential role in platelet aggregation at high shear
	-	A key role of the fast ATP-gated P2X₁ cation channel in the thrombosis of small arteries in vivo
	-	Impaired thrombus formation in a murine model of glycoprotein VI deficiency
	-	A key role of the fast ATP-gated P2 X 1 cation channel in the thrombosis of small arteries in vivo
Marchese P.	-	Increased shear rate threshold in mouse blood for the dependence of platelet thrombus formation on glycoprotein Iba
Marchesi C.	-	Weight changes after acute deep venous throbosis: a prospective observational study
	-	Early developments of the post-thrombotic syndrome in overweight and obese patients
	-	Determinants of delayed thrombus regression after deep vein thrombosis of the lower limbs: a prospective cohort study
Marchetti M.	-	The synthetic retinoic acid receptor (RAR)-gamma agonist CD437 reduces procoagulant activity and induces apoptosis in breast cancer cells
Marchetti M.	-	Low-molecular weight heparin (LMWH) enoxaparin counteracts the expression of endothelial cell tissue factor elicited by malignant cells
	-	Effect of the LMWHs dalteparin and enoxaparin on tissue factor and thrombomodulin expression by endothelial cells
Marchetti M.	-	Role of polymorphonuclear (PMN) leukocyte activation in the formation of PMN-platelet aggregates in Essential Thrombocythemia (ET) and Polycythemia Vera (PV)
	-	Low-molecular weight heparins (LMWH) modulate the functional adhesion of tumor cells to the vascular endothelium
Marchetti G.	-	Impaired prothrombinase activity of Factor X Gly381Asp results in severe familial CRM + FX deficiency
Marchi R.	-	Anti-fibrinogen IgG from a thrombophilic A alpha R16C (Fibrinogen Northspring) proband accelerates release of clot bound thrombin by enhancing fibrinolysis: a novel thrombogenic mechanism
Marchini L.	-	Diagnosis of deep vein thrombosis in hospitalized elderly patients: poor discriminant value of clinical pretest probability unless integrated by d-dimer assay
Marchini F.	-	Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
Marchioli R.	-	A randomized clinical trial of oral anticoagulant therapy in patients with the antiphospholipid syndrome: the WAPS study
Marchiori A.	-	The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study
	-	Atherosclerosis as a potential risk factor of venous thrombosis
	-	Symptomatic chronic thromboembolic pulmonary hypertension after symptomatic pulmonary embolism: incidence and risk factors: a long-term follow-up study
Marchiori A.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Marchiori A.	-	Below-knee elastic compression stockings for prevention of the post–thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study
Marcinkiewicz M.	-	Thrombin-induced platelet signaling results in factor IXa binding to a subpopulation of platelets with low or absent GP1b antigen
	-	Binding to a negatively charged surface alters the conformation of factor XIa
	-	Autophosphorylation of focal adhesion kinase at Tyr397 in collagen-stimulated human platelets
Marco P.	-	Myocardial infarction in young patients: risk factors and thrombophilia study
Marco P.	-	Acquired hemophilia: a multicentric study. Spanish group on acquired hemophilia
Marco P.	-	Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers
Marco P.	-	Prospective study of the risk factors for the development of post–thrombotic syndrome after proximal deep vein thrombosis
Marco P.	-	Hemostatic markers in nonrheumatic atrial fibrillation patients without anticoagulant therapy
Marco I.	-	Retrospective analysis of heritable thrombophilia in 90 children with Legg-Perthes disease
Marcucci R.	-	Protein Z levels in acute coronary syndromes
Marcucci R.	-	Increased lipoprotein(a) levels as an independent risk factor for idiopathic and recurrent venous thrombosis
Marcucci R.	-	Emerging prognostic factors in ischemic heart disease
	-	Homocysteine plasma levels in primary biliary cirrhosis (PBC)
	-	Assessment of platelet function during cardiopulmonary bypass using two new "point of care" devices
Marcucci R.	-	Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
Marculescu R.	-	A microsatellite polymorphism in the Heme Oxygenase – 1 gene promoter is associated with increased serum bilirubin and HDl levels but not with a decreased risk for coronary artery disease
Marcus A. J.	-	CD39 ecto-nucleotidase activity (metabolizing ATP to ADP to AMP) constitutes a homeostatic mechanism for control of platelet reactivity, depending on the ratio of ADPase to ATPase activity. Results from patients with coronary artery disease
Marder V.	-	Distinct dose-dependent effects of plasmin and TPA on coagulation and haemorrhage
Marder V. J.	-	Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement
Mardla V.	-	Comparison of platelet aggregation in venous and arterial blood
Maree A.	-	Evaluating 'aspirin resistance' in a population with cardiovascular disease
Marenzi G. C.	-	Platelet-associated Tissue Factor expression in patients with unstable coronary artery disease
Marès P.	-	Anti-protein Z antibodies in women with abnormal pregnancies
	-	Antiphospholipid/antiprotein antibodies and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study
Maret D.	-	Polymorphisms in the 3'-untranslated region of the TAFI mRNA modulate TAFI gene expression through control of mRNA stability
Margaglione M.	-	Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
Margaglione M.	-	Polymorphisms in the thrombomodulin gene as risk factors for myocardial infarction (HIFMECH study)
	-	Women with common prothrombotic mutations are not at higher risk of recurrent intrauterine fetal deaths
	-	Modulation of clinical phenotype of Glanzmann's Thrombasthenia by the C807T alpha2 gene polymorphism
Margaglione M.	-	FV plasma levels and the activated protein C resistance phenotype are modulated by the FV gene Asp79His polymorphism in presence of the FV Leiden mutation
Margaglione M.	-	Endothelial nitric oxide synthase gene variation and hypertension in pregnancy
	-	Genetically defined protein S (PS) deficiency is associated with venous thrombosis
	-	The strong incidence of acquired and inherited thrombophilia in recurrent first trimester fetal loss
	-	Prevalence of haemostatic abnormalities in women with 3 or more implantation failures after in vitro fertilization
	-	PROSIT: functional analysis of identified PROS1gene mutations
Margarita A.	-	Pro-atherogenic role for IgG antioxidised-low-density-lipoprotein-beta-2-glycoprotein-I complex in primary antiphospholipid syndrome
	-	Elevated plasma factor XIII relates to intima media thickness of carotid arteries in primary antiphospholipid syndrome
Margheri M.	-	New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
Mari R.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Mari D.	-	Hemostasis and inflammation in advanced heart failure and after successful heart transplantation
Mariani G.	-	Development of inhibitors against factor VII in patient with severe factor VII deficiency
	-	Chemotherapy-induced activation of hemostasis: the role of d-dimer
	-	Heterogeneous molecular pattern of Factor VII deficiency associated to cerebral hemorrhage
	-	Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
Marietta M.	-	Reduced platelet sensitivity to nitric oxide donors in patients with a history of preeclampsia
Marietta M.	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Marietta M.	-	Elevated plasma levels of factor VIII in women with early recurrent miscarriage
Marín F.	-	Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
Marin F.	-	Hemostatic markers in nonrheumatic atrial fibrillation patients without anticoagulant therapy
	-	Myocardial infarction in young patients: risk factors and thrombophilia study
Marinakis TH.	-	Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Marinho A.	-	Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
	-	The prognostic value of platelet count drop in an intensive care unit
Marino R.	-	Short-term effects of raloxifene on the main anti-coagulant systems in postmenopausal women
Marino S.	-	‘Video Grand Rounds’: an assessment of internet based grand rounds to increase collaboration between comprehensive hemophilia treatment centers
Mariotti S.	-	Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Markakis K.	-	Recombinant FVIIa for the treatment of severe bleeding in patients with hematological malignancies and thrombocytopenia
Marks S.	-	20 years multicentre study to investigate the prevalence of prothrombotic disorders in neonatal renal venous thrombosis (RVT) in Canada
Marongiu F.	-	G20210A prothrombin mutation and allele 4G of gene PAI-1 in deep vein thrombosis
	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
	-	Fasting homocysteine levels in predicting post methionine loading test results
	-	G20210A prothrombin mutation and factor V Leiden (G1691A) to address local health policy
	-	Visceral vein thrombosis: retrospective analysis of 53 cases in five Italian thrombosis
Marov S. V.	-	Low molecular heparin in prophylaxis of thrombohamorragic complications after caesarean delivery in patients with cardiologic deseases
Marques C.	-	Treatment of acquired factor VIII inhibitor using Feiba and Prednisone
Marre P.	-	Why did rFVIIa have no effect in post delivery bleeding? – a case-report
Marret H.	-	Inherited risk factors are different in pregnant and nonpregnant women with venous thromboembolism
Marroni M.	-	Chlamydia pneumoniae seropositivity is associated with increased inflammatory characteristics in atherosclerotic plaques
Marsál K.	-	Coagulation factor V Leiden not increased in pregnancies complicated by abruptio placentae
Marsden L.	-	Fluorescent conformation sensitive gel electrophoresis (F-CSGE) analysis of the VWF gene: A high throughput, sensitive mutation detection system
Marsden L.	-	Basal Fibrinogen and FVIII:C Concentrations are not Associated with Polymorphisms in the Interleukin-1 Gene Cluster
Marsden K.	-	Laboratory assessment of acquired thrombophilia: current and past experience in Australasia with lupus anticoagulant (LA) and anti-cardiolipin antibody (ACA) testing
Marsden L.	-	Can full-length wild-type von Willebrand factor (VWF) or the VWF propeptide rescue secretion of the R273W VWF variant associated with quantitative deficiency?
Marsden K.	-	Laboratory diagnosis of congenital thrombophilia: current and past practice in Australia
	-	Laboratory diagnosis of von Willebrand Disorder: current and past practice in Australasia
Marsh C.	-	Proteomic identification of tissue factor regulatory components in blood monocytes
Marsh J. J.	-	A novel method of measuring fibrinopeptide B for the detection of venous thromboembolism
Marshall G. J.	-	Oral infection as a risk factor of atherosclerosis: first results of an intervention study
Marshall N. J.	-	The CRP-VLDL complex, a predictor and marker of DIC, exists in vivo
Marshall D.	-	Prophylactic factor replacement therapy in children with severe factor X deficiency
Marshall S. J.	-	The interaction of von Willebrand factor with GPIba; induces GPIIb-IIIa-dependent secretion
Martchev D.	-	Thrombosis risk factor assessment in surgical patients: compliance with chest consensus guidelines
	-	Thrombosis prophylaxis following total hip replacement
Martelli N.	-	Beta-2 integrin adhesion triggered by E-selectin in human PMN: role of SRC kinases and of an unidentified receptor
Martenelli I.	-	Risk for recurrent venous thromboembolism among patients with severe inherited thrombophilia
Martí-Fábrega J.	-	The 46C®T polymorphism in the F12 gene is a risk factor for ischemic stroke
Marti-Fabregas A.	-	Risk of ischemic stroke (IS) associated with plasma levels of thrombin-activatable inhibtor fibrinolysis (TAFI)
Martin J.	-	Endothelial and angiogenesis activity in terminal heart failure and heart-transplant patients: a prospective study
Martin A.	-	An in vitro model for assessing the thrombogenic potential of mechanical prosthetic heart valves
	-	A microscopic evaluation of the influence of fluid dynamics on the clotting of a blood analog fluid
Martín J.	-	Inflammation and thrombogenic activity in terminal heart failure patients and heart transplantation: a prospective study
Martin J.	-	The Jarvik 2000 artificial heart does not affect the activation status of platelets
Martin Suarez A.	-	Population pharmacokinetics of the ReFacto coagulation factor VIII in clinical hemophilia patients with HIV
Martinelli I.	-	Embryo implantation after assisted reproductive procedures and maternal thrombophilia
Martinelli N.	-	Low vitamin B₆, markers of inflammation, and coronary artery disease
Martinelli F.	-	Dental implants in anti-coagulated out-patients
Martinelli N.	-	Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis
Martinelli I.	-	Inherited thrombophilia and hyperhomocysteinemia in upper limb deep vein thrombosis
Martinelli N.	-	Modulation of factor V levels in plasma by intragenic polymorphisms
Martinelli P.	-	Endothelial nitric oxide synthase gene variation and hypertension in pregnancy
Martinelli I.	-	High risk of cerebral-vein thrombosis in patients with hyperhomocysteinemia
Martinelli F.	-	High plasma homocysteine concentrations in cerebrovascular patients with Fabry disease
Martinez J. G.	-	Myocardial infarction in young patients: risk factors and thrombophilia study
Martínez M.	-	Interferon and ribavirin in patients with chronic hepatitis C and congenital bleeding disorders
Martinez E.	-	Single-dose use of recombinant factor VIIa (NovoSeven) for correction of hepatic-induced coagulopathies prior to minor, invasive procedures
Martínez J.	-	Treatment with recombinant activated factor VII of intra-abdominal bleeding associated with disseminated intravascular coagulation caused by septic shock
Martínez M.	-	Platelet–erythrocyte interactions enhance GPIIbIIIa receptor activation and P-selectin expression during platelet recruitment. These effects are amplified in type I diabetic patients
Martinez M.	-	Preconceptional and gestational enoxaparin regimes adjusted to fertility program to prevent preclinical, embryonic and fetal loss in women with Recurrent Pregnancy Loss (RPL) and thrombophilia
Martinez E.	-	Use of constant infusion of recombinant factor VIIa (NovoSeven) in the management of a recurrent subdural hematoma in a patient with severe hepatic coagulopathy
Martinez C.	-	Platelet septins and enhanced platelet function in SEPT5-deficient platelets
Martínez V.	-	Clinical manifestation of severe hemophilia B ameliorated by Prothrombin 20210A
Martínez M.	-	Natural history of hepatitis C infection in hemophilia patients at Hospital Universitario Virgen del Rocío (Sevilla, Spain)
Martinez C.	-	A new evidence of a relationship between store-operated calcium entry and the regulation of procoagulant phosphatidylserine exposure at the surface of stimulated cells
Martínez C.	-	Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
Martínez M.	-	Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
Martínez A.	-	The 46C®T polymorphism in F12 gene is a risk factor for coronary artery disease
Martinez M. C.	-	The coordinated transcription of genes encoding regulators of cell cycle progression revealed by expression profiling upon calcium ionophore A23187 treatment of B lymphoblasts from a patient with Scott syndrome
Martínez C.	-	Detection of conformational transformation of antithrombin in blood by crossed immunoelectrophoresis: new application for a classical method. Effect of temperature in plasmatic antithrombin; role in senescence of antithrombin and thrombosis
	-	Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
Martinez Saguer I.	-	Favourable course of hemorrhagic complication in early pregnancy of a patient with congenital afibrinogenemia under replacemant therapy
	-	Long-term prophylaxis with FEIBA® in patients with high-responding inhibitors
Martinez-Marchan E.	-	Factor VII plasma levels and the F7 structural gene: complete dissection of a human quantitative trait locus
	-	Complexity of the genetic contribution to Factor VII deficiency in two Spanish families: clinical and biological implications
Martinez-Pinna J.	-	Quantification of the platelet-generating demarcation membrane system in living megakaryocytes
Martinez-Saguer I.	-	Clinical manifestation and therapy in children with hereditary angioedema (HAE) – a prospective follow up
Martinez-Saguer I.	-	Successful immune tolerance therapy in hemophilia B patients with fix: a new immunesuppressive strategy
Martínez-Sales V.	-	Endothelial and angiogenesis activity in terminal heart failure and heart-transplant patients: a prospective study
Martinez-Sales V.	-	Inflammation and thrombogenic activity in terminal heart failure patients and heart transplantation: a prospective study
Martínez-Sales^*	-	Insufficient thromboxane A2 inhibition in patients with vascular disease chronically treated with aspirin: implications for platelet function
Martinez-Sanchez E.	-	Factor VII plasma levels and the F7 structural gene: complete dissection of a human quantitative trait locus
	-	Complexity of the genetic contribution to Factor VII deficiency in two Spanish families: clinical and biological implications
	-	Genetic coregulation of C4b-binding protein (C4BP) and free Protein S plasma levels: a link between complement and hemostasis
Martini F.	-	Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Martini F.	-	In vivo platelet activation is associated to increased plasma levels of vascular endothelial growth factor – effects of aspirin treatment
Martinkova I.	-	The anti-thrombin variant -6Arg is a silent mutation
Martin-Mcnulty B.	-	Activated thrombin–activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs
Martinotti S.	-	NAD(P)H oxidase C242T gene variations and cardiovascular protection
Martins E. C. S.	-	Effects of isolated and combined use of ticlopidine, clopidogrel and aspirin on platelet function as evaluated by platelet aggregometry
Martins R.	-	Evaluating the interaction of allopurinol with the oral anticoagulants
Martin-Toutain I.	-	Comparison of inherited and acquired thrombophilia in cerebral venous thrombosis and pulmonary embolism or deep vein thrombosis of the leg
Martinuzzo M.	-	Differences in Th1- and Th2-like cytokine patterns between patients with antiphospholipid syndrome and with lepromatous leprosy-related aPL
Martinuzzo M.	-	Autoantibodies to TFPI are associated with definite APS but not with infection-related aPL
	-	Inherited and acquired prothrombotic risk factors in women with early or late pregnancy losses
	-	Evaluation of protein Z (PZ) and protein Z-dependent protease inhibitor (ZPI) plasma levels and the in vitro inhibition of activated factor X by PZ/ZPI in patients with autoimmune aPL
Maruhn B.	-	High levels of plasma markers of coagulation factor VIII:C and von Willebrand factor are independent risk determinants of pregnancy-associated venous thromboembolism
	-	Platelet receptor polymorphisms of glycoprotein (GP) Iba VNTR, GP IIb-IIIa (HPA–1), and GP Ia C807T and the risk of premature myocardial infarction
Marutsuka K.	-	Localization and activity of ecto-ATP diphosphohydrolase/CD39 in human tissues
	-	Coagulation system and inflammation significantly contribute to thrombus formation in ruptured plaques than erosive plaques of acute myocardial infarction
	-	Combination of increased vascular thrombogenesity and blood flow alteration promote obstructive thrombus formation in rabbit femoral artery
Maruyama I.	-	Activated protein C as a proteolytically activable antioxidant, anticoagulant protein
	-	2-Arachidonoylglycerol (2-AG) endocannabinoids, induces platelets conjugation with neutrophils (Platelet Satellitism) in vitro
Maruyama I.	-	The natural anticoagulant Thrombomodulin has radical scavenging activity and acts as an antioxidant C-type lectin
Maruyama I.	-	Endothelial anticoagulant thrombomodulin (TM) as a natural anti-inflammatory, ‘HMG1 blocker’, inhibits pro-inflammatory cell activation
Marx P. F.	-	Complex formation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) with fibrin(ogen)
Marx P. F.	-	Generation and characterization of a highly stable form of activated TAFI
Marzec U. M.	-	Inhibition of tissue factor initiated thrombosis in vivo
Marzec U.	-	Dose-dependent inhibition of thrombosis by melagatran in a nonhuman primate model
	-	Experience of using FEIBA™ to attenuate the effects of anticoagulation on inhibition of thrombogenesis in primates
Marzec U. M.	-	CTRP1 – a vascular wall protein that can prevent platelet thrombosis without causing bleeding
Marzec U.	-	Quantification, as well as functional and phenotypic characterization, of baboon platelet- and plasma-derived factor V demonstrate near identity with human factor V pools
Marziliano N.	-	A 3' untranslated region (3' UTR) variation on the factor VII (FVII) gene changes completely the phenotype due to the Arg277Cys mutation in a patient with Type I FVII deficiency
Marzinotto V.	-	Ex vivo thrombin generation capacity in pediatric patients receiving Tinzaparin
	-	A pharmacokinetic study of tinzaparin in pediatric patients
	-	Use of low molecular weight heparin in children with thromboembolic events; predictors for bleeding and recurrence on therapy
Mas J. L.	-	Genetic polymorphisms and the risk of development of ischemic stroke. Result of a case control study
Masala C.	-	In vivo platelet activation is associated to increased plasma levels of vascular endothelial growth factor – effects of aspirin treatment
Masamura K.	-	Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family
Masao N.	-	ADP regulates the expressions of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1(PAI-1) in rat aortic endothelial cells
Masenko V. P.	-	Leukocyte–platelet interaction: modulation by lipids of different density and inhibition by high dose of catecholamines
Maslen K. E.	-	Prediction and prevention of thrombosis during pregnancy and oestrogen use
Mason M. J.	-	Quantification of the platelet-generating demarcation membrane system in living megakaryocytes
Massaro M.	-	Statins inhibit cyclo-oxygenase (cox)-2 and metalloproteinase (mmp)-9 expression in human endothelial cells: possible contribution to plaque stability
Massaro A. R.	-	Inherited prothrombotic risk factors in a Brazilian cohort with CVT
	-	Acquired prothrombotic-associated factors in cerebral venous thrombosis (CVT)
Massaro M.	-	Insulin enhances vascular cell adhesion molecule (VCAM-1) expression in human cultured endothelial cells – a link to the pathogenesis of accelerated atherosclerosis in diabetes
Massi Benedetti M.	-	Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients
Massicotte M. P.	-	Poor correlation between aPTT, anti-Xa levels and heparin dose in children receiving therapeutic doses of unfractionated heparin
Massicotte P.	-	Use of low molecular weight heparin in children with thromboembolic events; predictors for bleeding and recurrence on therapy
Massicotte M. P.	-	A pharmacokinetic study of tinzaparin in pediatric patients
Massicotte P.	-	Central venous line-related thrombotic events in children: association with duration of line placement, type, size, and location
Massicotte M. P.	-	Very low dose warfarin for primary and secondary prophylaxis in children: a prospective cohort study of 20 children
	-	Reversal of low molecular weight heparin (LMWH) prior to invasive procedures using subcutaneous unfractionated heparin in children with an ongoing high risk for thrombosis
Massicotte P. M.	-	Venous thrombosis in children
Massicotte M. P.	-	Low molecular weight heparin therapy in neonatal cerebral sinovenous thrombosis: a consecutive cohort study
	-	A case series of 72 neonates with renal vein thrombosis: data from 1 to 800-No-Clots registry
Massicotte P.	-	Ex vivo thrombin generation capacity in pediatric patients receiving Tinzaparin
	-	Use of LMWHs in pediatric patients
Massicotte M. P.	-	A dose-finding study of Tinzaparin in pediatric patients
Massicotte P.	-	Central venous catheter-related thrombosis presenting as SVC syndrome in a hemophiliac with inhibitors
Massicotte M. P.	-	Vena cava filters in children: review of a single centre clinical experience over 7 years
	-	Reversal of warfarin or low molecular weight heparin (LMWH) using subcutaneous unfractionated heparin (UFH) in pediatric outpatients with an ongoing high risk for thrombosis and requiring invasive procedures: a prospective cohort study of 146 children
Massot M.	-	Limited ability of nonactivated partial thromboplastin time to monitor clotting factors activation in high purity/high potency Factor IX concentrates
Mast A. E.	-	Glycosyl Phosphatidylinositol (GPI)-anchored protein(s) are required for cell surface expression of tissue factor pathway inhibitor (TFPI)
	-	Binding at two distinct exosites is required for activation of prothrombin by prothrombinase
Mast A.	-	Structure function of tissue factor pathway inhibitor
Masuda Y.	-	A novel ELISA method for soluble fibrinogen and fibronectin complexes (FG–FN) in normal adult's and DIS patient's plasma
Mateo J.	-	Genetic dissection of thrombin-activatable fibrinolysis inhibitor (TAFI)
	-	The 46C®T polymorphism in F12 gene is a risk factor for coronary artery disease
	-	Risk of ischemic stroke (IS) associated with plasma levels of thrombin-activatable inhibtor fibrinolysis (TAFI)
	-	The 46C®T polymorphism in the F12 gene is a risk factor for ischemic stroke
	-	The 46C®T polymorphism in the F12 gene as a risk factor for venous thrombosis: association after linkage analysis
	-	Complexity of the genetic contribution to Factor VII deficiency in two Spanish families: clinical and biological implications
Mateos M. V.	-	Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Matetzky S.	-	Monitoring the combined effect of integrilin, clopidogrel and aspirin in patients with myocardial infarction by Cone and Plate(let) Analyzer
Mather H.	-	A thrombomodulin (TM) gene promoter variant (TM-33G > A) in type 2 diabetes
	-	Soluble endothelial cell markers (sTM, sEPCR and sVWF) in type 2 diabetes
Mathias M.	-	Subcutaneous administration of protein C
	-	Transient lupus anti-coagulant directed against factor II
Mathiesen E. B.	-	Inflammation and endothelial dysfunction in patients with carotid stenosis
Mathieux V.	-	Risk of pregnancy-related venous thromboembolism (VTE) in 60 hereditary AT-deficient women from 45 families: study of 164 pregnancies
Mathonnet F.	-	Prevalence of methylenetetrahydrofolatereductase (MTHFR) gene polymorphism (C677T) in the Moroccan population
Matijevic-Aleksic N.	-	Coexistence of multiple hemostatic genetic risk factors does not increase risk of coronary heart disease: The ARIC Study results
Matos M. F.	-	Comparative analysis of methods for detection of Activated Protein C resistance: an analysis of 755 consecutive patients
Matos E.	-	The prognostic value of platelet count drop in an intensive care unit
Matos M. F.	-	Use of a decision-making system based on the Fuzzy sets theory applied to the routine of results' release in the haemostasis laboratory: how to do it better and quicker
Matos E.	-	Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
Matos M. F.	-	Effects of isolated and combined use of ticlopidine, clopidogrel and aspirin on platelet function as evaluated by platelet aggregometry
Matou S.	-	A new co-operative effect of low molecular weight polysaccharides and cell surface heparin sulfate in enhancing bFGF-induced endothelial cell differentiation
Matsuda M.	-	Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with DIC
Matsuda J.	-	Ligand for peroxisome proliferator-activated receptor-a (PPARa) Down-regulates tumor necrosis factor - a-induced pro-coagulant activation of tissue factor through inhibition of ap-1-dependent gene transcription in human endothelial cells
Matsuda M.	-	Blood coagulation during mural throbogenesis under whole blood flow conditions with high shear rates
	-	Mural thrombus generation in classic hemophilia under whole blood flow conditions
Matsuda J.	-	Oxidation products of common phospholipid specifically impair the activity and the reactivity of tissue factor pathway inhibitor
Matsui H.	-	Mural thrombus generation in classic hemophilia under whole blood flow conditions
Matsui H.	-	Blood coagulation during mural throbogenesis under whole blood flow conditions with high shear rates
Matsumoto T. M.	-	Frequency of biphasic transmittance waveform in the APTT coagulation assay in the patients with underlying diseases of DIC
Matsumoto M.	-	D1596-R1668 of von Willebrand factor is a minimal region recognized as a specific substrate for ADAMTS-13
Matsumoto L. A.	-	Venous thromboembolism (VTE) in children: a series of cases from a pediatric Brazilian cohort
Matsumoto M.	-	Localization and activity of ecto-ATP diphosphohydrolase/CD39 in human tissues
Matsumoto C.	-	The effect of direct FXa inhibitor and direct thrombin inhibitor on TF induced DIC and venous thrombosis models in anesthetized rat – thrombin inhibitor enhance the platelet consumption in DIC model
Matsumoto T.	-	Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with DIC
Matsumoto T.	-	The hemostatic effectiveness of regular infusions of factor VIII concentrates in hemophilia A patients with high responder inhibitors
Matsumoto K.	-	Clinical significance of endothelial hemostatic markers in patients with ischemic heart disease
Matsumoto M.	-	Mutations of ADAMTS13 gene in four Japanese families with Upshaw–Schulman syndrome
Matsumoto T.	-	Population-based study of acquired hemophilia A
Matsumoto C.	-	DX-9065a, a direct factor Xa inhibitor prevents both arterial and venous thrombosis in rats via blocking prothrombinase complex activity – comparison with fondaparinux, an antithrombin dependent factor Xa inhibitor
Matsumura R.	-	Hemophilia A gene therapy using the third-generation lentiviral vector – Mouse model
Matsuno H.	-	Lack of a2-antiplasmin promotes endothelial healing via over-release of VEGF after vascular injury in mice
	-	Lack of a 2-antiplasmin promotes endothelial healing via over-release of VEGF after vascular injury in mice
Matsuo O.	-	Lack of a 2-antiplasmin promotes endothelial healing via over-release of VEGF after vascular injury in mice
Matsuo T.	-	Usefulness of the prothrombin level measured by the carinactivase-1 method as the parameter of the coagulation activity during chronic warfarin therapy
Matsuo O.	-	Regulation of plasminogen activation at the surfaces of mouse hepatocyte
	-	Lack of a2-antiplasmin promotes endothelial healing via over-release of VEGF after vascular injury in mice
	-	Transcription of plasminogen gene in mouse hepatocytes is regulated by cellular density
Matsuoka T.	-	Anti-thrombotic effects of ER112787, a novel, nonpeptide thrombin receptor (PAR-1) antagonist, in a photochemically induced thrombosis model using guinea pigs
Matsushima G.	-	Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Matsushita T.	-	Ryudocan (syndecan-4) deficiency increases susceptibility to LPS-induced shock in mice
Matsushita T.	-	Abnormal subcellular localization of neutrophil nonmuscle myosin heavy chain-A (NMMHCA) is associated with MYH9 mutations in patients with autosomal dominant macrothrombocytopenia with leukocyte inclusions
Matsuura E.	-	IgG autoantibodies to OxLig-1/B2GPI complex are associated with arterial thrombosis in patients with anti-phospholipid syndrome
	-	OxiLDL/b2GPI complexes are frequent in SLE whereas autoantibodies to oxLig-1/b2GPI are more prevalent in patients with antiphospholipid syndrome
	-	Pro-atherogenic role for IgG antioxidised-low-density-lipoprotein-beta-2-glycoprotein-I complex in primary antiphospholipid syndrome
Matsuzawa Y.	-	Analysis of Arg-Gly-Asp contact sites in the av subunit of integrin avb3 employing single amino acid mutations
	-	Interaction of CD47 with SHPS-1 negatively regulates platelet function
	-	Demonstration of activation of integrin aIIbb3 by inside-out signaling in a megakaryocytic cell line, CMK
Matta M.	-	High prevalence of aspirin resistance in patients with acute coronary syndromes
Mattar L.	-	Anti-thrombotic effect of combination of low molecular weight heparin with low doses of unfractionated heparin in experimental venous thrombosis
Mattson J. C.	-	Variability in antifactor Xa assay procedures
Mattsson C.	-	The relative importance of P2Y12/P2Y1 in thrombin/ADP-induced platelet activation and true synergistic action in-between inhibition of P2Y12 and P2Y1
Matulis M. D.	-	A simplified assay for VWF cleaving protease (ADAMTS-13) activity and inhibitor in plasma
Matveeva M.	-	The effect of clopidogrel on walking distance and hemostasis in patients with intermittent claudication
Maugeri N.	-	Prostacyclin protects basal and nitric oxide-induced megakaryocytes apoptosis
Maugeri N.	-	Characterization of the von Willebrand factor present in circulating PMN
Maunier T.	-	A dedicated system for standardized measurement of VASP phosphorylation in blood platelets and detection of thienopyridine resistance
Maurer-Spurej E.	-	The effect of selective serotonin reuptake inhibitor anti-depressants on platelets
	-	Heat shock treatment induces stress tolerance in platelets
Maurice P.	-	Primordial role of the P2Y12 ADP receptor in different phases of platelet–collagen interactions
Mauser-Bunschoten E. P.	-	An evaluation of 30 years of hemophilia treatment in the Netherlands
	-	Effects of bleeds on health-related quality of life in patients with hemophilia
	-	The relation between clinical phenotype and genotype of severe hemophilia A
	-	Mortality of Dutch hemophilia patients, a prospective follow-up of 973 patients, 1992–2002
	-	High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
Mauzurov A. V.	-	Ligand binding to GP IIb–IIIa and stimulation of platelet release reactions
Mavri A.	-	Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
	-	Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Mavri A.	-	Safety of the transfer of patients on anticoagulant therapy from hospital anticoagulant clinics to general practitioners using a computer-decision support
	-	Comparison of a computer-based dosing program ‘Trombo’ with a manual dosing to monitor anti-coagulant therapy
Maxwell M. J.	-	Mechanotransduction through glycoprotein Iba induces a unique series of morphologic changes in translocating platelets
Maxwell A. H.	-	Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
May J.	-	The effects of three anti-platelet drugs (aspirin, clopidogrel, dipyridamole) given singly or together on platelet and leukocyte function in healthy subjects and patients with previous ischemic stroke
May Z.	-	Thrombolytic therapy in acute ischemic stroke: same method, same team, different drug
May P. E.	-	Reducing body iron stores lowers inflammatory cytokine levels in atherosclerotic claudicants
May M. A.	-	Changes in the platelet count (PC) after cardiopulmonary bypass (CPB) can efficiently predict the development of pathogenic heparin- dependent antibodies (Abs)
May J. A.	-	Thromboxane A2 is a weak platelet agonist requiring coactivation of both the P2Y1 and the P2Y12 receptors for full platelet activation to occur
Maybury H.	-	Changes in thromboelastography in low-risk women in the puerperium
Mayuga M.	-	Differential effects of unfractionated heparin and a low molecular weight heparin on anti-thrombin activity during the treatment of deep vein thrombosis
	-	Influence of argatroban alone and combined with oral anticoagulants on the assessment of coagulation factors
Mazoyer E.	-	A comparative pharmacodynamic study of anti-Xa activity to evaluate the accumulation effect of Tinzaparin and Enoxaparin given at prophylactic dose over 8 days in elderly patients with impaired renal function
	-	Lack of correlation between HPA1 polymorphism and ADP induced platelet activation: study of a large cohort of normal subjects
Mazoyer E.	-	There is no north/south gradient distribution of the plasma fibrinogen level and of the C-148T Fg genotype in a French native population (The Fitenat Study)
	-	Differential geographic distribution of Factor V Leiden and Factor II Leiden in a French native population (the Fitenat study)
Mazoyer E.	-	Influence of R353Q factor VII gene polymorphism on the plasma FVII levels in a French native population (The Fitenat Study)
	-	Age influence on D-Dimer in a large normal French population: the FITENAT study
	-	Aspirine resistance: a particularly high prevalence in patients after ventricular assist device implantation
	-	Early prediction of the sensitivity of warfarin in elderly patients by the fall in factor VII
Mazurek T.	-	Combination therapy with low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
	-	Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Mazurier C.	-	Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
	-	In vitro expression of 4 novel mutations identified in type 1 von Willebrand disease patients
	-	An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
	-	Type-2 mutations within the A1 domain of Von Willebrand Factor: how protein conformation modulates binding to platelet membrane GPIba
	-	Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
	-	Expression of a new candidate mutation, G1629R, identified in an Italian patient with type 2A von Willebrand disease
	-	Stability of 19 mutated recombinant von Willebrand factor to von Willebrand factor-cleaving protease (ADAMTS13)
	-	Mutation of cysteines 1157 or 1234 located within the D3 domain of Von Willebrand Factor causes intracellular retention of high molecular weight multimers
	-	Identification and expression of the first type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene
	-	Type 2N von Willebrand disease due to compound heterozygosity for the frequent R854Q type 2N mutation and a new R763G mutation abolishing the cleavage of von Willebrand factor propeptide
Mazzara R.	-	Granulocyte colony-stimulating factor exerts a pro-inflammatory effect on endothelial cells through activation of p38 MAPK
Mazzoni M. R.	-	Differences in protease activated receptor-1 stimulation between vWF and P-selectin release in endothelial cells-implications of distinct signaling of Weibel–Palade release
Mazzucato M.	-	Lagrangian modeling of platelet adhesion and its application to experimental data
	-	Crucial role of the ADP receptor P2Y1 in platelet adhesion and signaling under high flow
Mazzucconi M. G.	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
	-	Enhanced thrombin generation and mild bleeding tendency in a severely FVII-deficient patient carrying FV Leiden
	-	Thrombophilic screening in patients with paroxysmal nocturnal hemoglobinuria
	-	Hemophilia in pediatrics: clinical experience in a single hemophilia center
Mc Carthy P.	-	Improving the quality of INR determination in the anticoagulation clinic
Mc Cullough J.	-	Stored platelets contain residual amounts of tissue factor
Mc Gregor J. L.	-	Functional studies of P-selectin polymorphism's associated with coronary diseases
Mcbane R. D.	-	Risk of recurrence of cerebral venous and sinus thrombosis, influence of treatment
	-	Occurrence and management of abciximab induced pseudothrombocytopenia
	-	Cerebral venous sinus thrombosis. The spectrum of risk associated with this unique thrombotic disorder
Mcbride S.	-	Platelet CD109: evidence for a transmembrane homologue on monocytes?
	-	Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
Mccahon D.	-	An evaluation of four methods of external quality assurance (EQA) for patient self-management (PSM) of oral anti-coagulation: report on 97 patients
Mccain A. S.	-	Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
Mccallum S.	-	The Rapidpoint™ ENOX point-of-care test has strong correlation with anti-Xa levels for detecting the anti-coagulant effects of enoxaparin
Mccarthy C. J.	-	Use of specific reference ranges for equal volume mixing studies in lupus anticoagulant assays
Mccarty D.	-	Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
Mcclelland A.	-	A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Mcclintock R. A.	-	Crystal structure of the amino terminal domain of glycoprotein Iba in complex with a-thrombin
Mccoll M. D.	-	The effect of low and high dose aspirin on the expression of monocyte tissue factor
Mccollum P. T.	-	Investigations on the regulation of vascular smooth muscle cell migration by tissue factor (CD142)
Mccollum C. N.	-	Anticoagulant prophylaxis usage in cancer patients undergoing treatment
Mcconnachie A.	-	Effects of age, sex, and oral contraceptive use on hemostatic, fibrinolytic and inflammatory variables: cross-sectional population survey
	-	Associations of hemostatic and inflammatory variables with obesity and blood pressure in men and women aged 30–59 years: cross-sectional population survey
Mccorkle S.R.	-	Human blood platelets: RNA transcript profiling using microarray and serial analysis of gene expression
Mccormick A. N.	-	SPR evaluation of antibody-mediated inhibition of recombinant FVIII (full length and B-domain deleted) binding to von Willebrand factor
Mccowan L. M. E.	-	Inherited thrombophilias are not increased in ‘idiopathic’ small for gestational age pregnancies
Mccrindle B.	-	Frequency and predictors of vaso-occlusive strokes associated with cardiac surgery in infants and children with congenital heart disease
Mcculloch N.	-	Anticardiolipin antibodies and pregnancy outcome: a prospective study in an unselected obstetric population
Mccullough T.	-	Preclinical safety assessment of photochemically treated platelets: no toxicologically relevant effects with large multiples of the clinical exposure
Mccusker P. J.	-	Development of the Canadian hemophilia outcomes – Kids Life Assessment Tool (CHO-KLAT)
Mcdonald E.	-	Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
Mcdonald M. K.	-	Activation of platelets by HIT antibodies in vitro is not dependent on the presence of heparin
Mcdowell G.	-	Increase in platelet VEGF release in early breast cancer
Mcelwaine S.	-	Multivariate investigation of determinants of oral anti-coagulant stability
Mcevoy A. W.	-	Serial changes in hemostasis following subarachnoid hemorrhage
Mcgee B.	-	ADAMTS13 mutations identified in familial TTP patients result in loss of VWF-cleaving protease activity
Mcgettrick H. M.	-	Neutrophils rapidly recruited by TNF-a stimulated endothelial cells can exit the sub endothelial environment by reverse transmigration over hours: is this a novel route for neutrophil clearance from inflamed tissue?
Mcginn T.	-	Perioperative management of patients on oral anti-coagulants: a decision-analysis
Mcglasson D.	-	Elevated coagulation factors in rabbits (Oryctolagus cunniculus) following brown recluse envenomation (Loxoceles reclusa)
Mcgrath M.	-	An evaluation of preoperative hemostatic variables as risk factors for deep venous thrombosis after elective lower limb arthroplasty
	-	Diagnostic utility of Simplify d-dimer – a new d-dimer test for patients with suspected venous thromboembolism
	-	A single-center prospective study of clinical and genetic thrombophilic risk factors for deep venous thrombosis (DVT) in 510 patients undergoing elective lower limb surgery
Mcgrath J.	-	The stability of 11-dehydro thromboxane B2 levels in random urine samples
Mcgregor B.	-	Ischemia induces early and enhanced expression of a new transcription factor (6A3-5) in human and rat kidney vascular smooth muscle cells
Mcgregor J. L.	-	Ischemia induces early and enhanced expression of a new transcription factor (6A3-5) in human and rat kidney vascular smooth muscle cells
	-	Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
McGregor J.L.	-	Structural and functional characterization of a new transcription factor (6A3-5) potentially implicated in changes of smooth muscle cells phenotype
Mcintosh J. H.	-	Promotion of thrombin generation at low FVIII concentrations by FIXa
Mcintosh R. V.	-	Removal of a BSE-derived agent by ion exchange chromatography used in the manufacture of a high purity factor VIII concentrate
McIntosh N.	-	Catheter-related venous thrombosis in children diagnosed by magnetic resonance venography
Mckee P. A.	-	A novel plasma proteinase that enhances incorporation of a₂-antiplasmin into fibrin
Mckelvie S.	-	The rate of thrombus resolution following treatment of DVT is related to the site and the precipitating cause of thrombosis
Mckenzie S. E.	-	PF4 and heparin form high molecular weight complexes that is central to the pathogenesis of Heparin-Induced Thrombocytopenia
Mckinven A. J.	-	The use of three hemophilia A mouse models to illustrate strain-specific differences in immune responses to FVIII protein replacement via protein infusion or adenoviral gene therapy
Mckusick M. A.	-	Combined mechanical and pharmacologic thrombolysis for ilio-femoral deep venous thrombosis. Single center short-term outcomes
Mclaren M.	-	Dark chocolate inhibits platelet aggregation in healthy volunteers
	-	Soluble P-selectin and P-selectin expression (CD62P) both reflect the same in vivo platelet activation
	-	Increased plasma isoprostanes and other markers of oxidative stress in chronic fatigue syndrome
	-	Increased neutrophil apoptosis in chronic fatigue syndrome
Mclellan D.	-	Effect of warfarin anticoagulants on elements of the tissue factor pathway and other procoagulant markers
Mclimont M.	-	Final results from the Canadian hemophilia dose escalation prophylaxis trial
Mclintock C.	-	Inherited thrombophilias are not increased in ‘idiopathic’ small for gestational age pregnancies
Mcmahon A. D.	-	Population prevalence of atrial fibrillation and factors associated with use of warfarin
	-	Coagulation activation markers in atrial fibrillation: dose-dependent correlation with warfarin therapy
McMillan-Ward E. M.	-	Anti-CD63 monoclonal antibodies inhibit platelet spreading on immobilized fibrinogen
	-	Procoagulant activity of neonatal platelets
Mcmillen S.	-	Agreement between FXIII activity assays and calibrator plasma pools: the need for a FXIII reference standard with regulatory recognition
Mcnicol A.	-	Streptococcus sanguis-induced platelet signal transduction pathways involve both ITAMs and ITIMs
Mcphail I. R.	-	Combined mechanical and pharmacologic thrombolysis for ilio-femoral deep venous thrombosis. Single center short-term outcomes
Mcquillan A.	-	Low-molecular-weight heparin is as effective and safe as unfractionated heparin for the initial treatment of pulmonary embolism: a meta-analysis
McRedmond J.	-	An analysis of the platelet transcriptome using commercial microarrays
McVey J.	-	450 million years of haemostasis
Mcvey J.	-	Severe thrombophilia in two brothers due to novel combination of mutations in factor V gene producing quantitative deficiency (Glu119Term) and decreased sensitivity to activated protein C due to a novel glycosylation site (Ile359Thr-FV Liverpool)
	-	Targeted expression of tissue factor pathway inhibitor and hirudin fusion proteins to endothelial cells reduces pathology in murine LPS-induced endotoxic shock – a novel model to study vascular inflammation
	-	Expression of human tissue factor pathway inhibitor and hirudin fusion proteins on mouse vascular smooth muscle cells inhibits vascular remodeling after wire-induced carotid artery injury
Mcvey J. H.	-	Functional characterization of recombinant Factor V Liverpool: Ile350Thr, a novel mutation associated with thrombosis
McVey J. H.	-	Coagulation proteases factor Xa and factor VIIa do not mobilize intracellular calcium stores in human dermal fibroblasts
Mcvey J. H.	-	Two novel mutations in severe factor VII deficiency
Mcwhirter W.	-	Advoy – a communication tool for better care in haemophilia
Meade T. W.	-	The predictive value of C-reactive protein (CRP) for myocardial infarction may be affected by aspirin therapy in men with lower extremity arterial disease
	-	C-reactive protein (CRP) may predict death from cancer in men with lower extremity arterial disease
Meade G.	-	Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
Meade T. W.	-	Effect of bezafibrate on plasma homocysteine in men with lower extremity arterial disease
Meade M.	-	Levels of D-dimer do not predict deep venous thrombosis in medical–surgical ICU patients
	-	Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
Meade G.	-	Shear-induced activation of metastatic cells is enhanced by the platelet secreteome and inhibited by aspirin
Medina P.	-	The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene is associated with levels of soluble plasma EPCR
Medina P.	-	The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene reduces the risk of venous thromboembolism in carriers of the factor V Leiden mutation
	-	Synergy between deficiencies of plasma glucosylceramide and deficiency of activated protein C for venous thromboembolism
	-	Circulating activated protein C in Behcet's disease and risk of thrombosis
Medved L.	-	Structural aspects of fibrinogen to fibrin transition
Meede G.	-	Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
Meehan W. P.	-	CTRP1 – a vascular wall protein that can prevent platelet thrombosis without causing bleeding
Meengs B. L.	-	Cross–species interactions of FXIII and fibrinogen
Meer Van Der F. J. M.	-	A new computer algorithm for better dosage of oral anti-coagulants
Meesters E. W.	-	Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo
	-	Soluble tissue factor released by cultured human umbilical vein endothelial cells is microparticle-associated and triggers thrombus formation in vivo
Meidanis K.	-	Levels of plasma tissue activator plasminogen (tPA)- A useful marker in the differential diagnosis of chest pain (marker of plaque destabilization)
	-	Correlation between SVCAM, SICAM plasma levels, the outcome of treadmill test and the systolic function of left ventricular (LV) in patients with coronary artery disease
Meijer A. B.	-	Exposure of a binding site for the low-density lipoprotein receptor-related protein (LRP) upon activation of factor V
Meijer J.	-	Levels of endothelial activation markers, D-dimer fragments and pro-inflammatory cytokines and sickle cell disease severity
	-	Reduced protein C and S activity and sickle cell disease severity
Meijer A. B.	-	Cleavage of factor VIII heavy chain by thrombin increases the affinity for low-density lipoprotein receptor-related protein (LRP)
Meijer P.	-	The long-term analytical performance of assay of anti-thrombin, protein C and protein
Meijer K.	-	High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
Meijer A. B.	-	Molecular events involved in factor IXa stimulation by the factor VIII A2 domain
Meijer P.	-	Harmonization of D-Dimer test results
Meijer P.	-	Relevance of interindividual variability in d-dimer composition for comparison of assays
Meijers J. C. M.	-	Generation and characterization of a highly stable form of activated TAFI
Meijers J. M. C.	-	Effect of pravastatin on plasma markers of coagulation and inflammation in type 2 diabetes
Meijers J. C. M.	-	Incidence and risk factors for factor VIII antibodies in mild hemophilia A
	-	Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers
	-	High levels of coagulation factors IX or XI: risk factors for pulmonary embolism?
Meijers J. C.	-	Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia
Meijers J.C.M.	-	Regulation of coagulation - the role of TAFI
Meijers J. C.	-	Alterations in lipoprotein homeostasis during experimental and clinical sepsis in primates
Meijers J. C. M.	-	Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)
	-	Clopidogrel suppresses rebound coagulation after discontinuation of enoxaparin treatment in patients with acute coronary syndromes
	-	Coagulation factor profiles respond strongly during human endotoxemia
Meijers J. C.	-	Prospective assessment of the diagnostic accuracy of the ISTH criteria for the diagnosis of DIC
Meijers J. C. M.	-	Complex formation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) with fibrin(ogen)
	-	A proteomic approach to identify plasma lipoprotein-associated proteins with a potential role in atherothrombosis
	-	Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Meilhac O.	-	Pericellular plasmin induces smooth muscle cell anoikis
Meilhac O.	-	Metalloproteinase 9 and plasmin as secreted markers of complicated atherosclerotic plaques
	-	Effect of apolipoprotein(a) on plasminogen activation-induced apoptosis of vascular smooth muscle cells
	-	Protease-nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells
	-	Smooth muscle cell recolonization of the aneurysmal thrombus is prevented by storage of leukocyte elastase in fibrin matrix
Meili E.	-	Seven novel mutations leading to congenital coagulation factor XIII deficiency
Meili E. O.	-	Treatment of recurrent arterial thrombosis with hirudin in congenital afibrinogenaemia
Meinders A. E.	-	Decrease of thrombophilia variables by aggressive vs. conventional atorvastatin treatment in patients with type 2 diabetes mellitus
	-	Common genetic abnormalities in blood coagulation (Factor V Leiden, prothrombin G20210A) increase the incidence of central vein catheter related thrombosis
Meintjes C. J.	-	The use of the rotational thrombelastograph (ROTEG) in the quantification of the ‘lytic state’ during thrombolytic therapy: a comparative analysis in the subhuman primate
Meireles E.	-	Association of MTHFR and ACE gene polymorphisms in reflux associated with renal damage
	-	A different view on the inflammatory bowel disease – the role of adhesion molecules and angiogenic growth factors
Meiring M.	-	GPRP interferes with FXIIIa in localization to immobilized Fibrin(ogen) and with platelet deposition in different thrombosis models
Meiring M.	-	Selection and characterization of a novel factor XI inhibiting peptide by using phage display technology
Mekrache M.	-	Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at high shear rate occurs independently of aIIb3 engagement
Melchior C.	-	Interacting sites within Talin and the integrin b3 cytoplasmic tail
Melgar M.	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
Melis E.	-	The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia
Melis E.	-	Platelet recruitment in vivo to injured blood vessels is not prevented by GPIIb/IIIa antagonism
Melis E.	-	The cytoplasmic domain of tissue factor plays an important role in innate and adaptive immunity
Mellars G.	-	Identification of a family with discrepant von Willebrand factor collagen binding assays (VWF:CB)
Mellgren S.	-	Effect of short-term, low-fat vegetarian diet and walking program on coagulation
Melotti D.	-	A new preanalytical procedure using dried blood spot sample for total homocysteine determination
Melton III L. J.	-	Genetic susceptibility of venous thromboembolism: role of the procoagulant, anticoagulant, fibrinolytic, and acute inflammation pathways
Membre A.	-	Increased thrombin potential due to acquired activated protein C resistance in patients with lupus anticoagulants
Mencarelli S.	-	Lysosomal beta-N-acetylhexosaminidase is a primer of platelet activation
Mende K.	-	Characterization of the urinary metabolites of dipetarudin
Mendes-Ribeiro M.	-	Non-Hodgkin's lymphoma and antiphospholipid antibodies. Are they surrogate markers for relapse?
Mendizabal G.	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
Mendolicchio L.	-	Increased shear rate threshold in mouse blood for the dependence of platelet thrombus formation on glycoprotein Iba
Mendolicchio L.	-	Modulation of von Willebrand factor A1 domain binding to glycoprotein Iba by a-thrombin
Meneghetti G.	-	Prevalence and impact on clinical outcome of concomitant peripheral arterial disease (PAD) in patients with coronary and cerebrovascular diseases: the Pathos project
Meng X.	-	Terminal intron splicing of the prothrombin premRNA is associated with 3'-cleavage site recognition and polyadenylation
Meng Y. G.	-	Differential use of variable domains of D3H44 antibody in binding to tissue factor or to an anti-idiotypic antibody
Meng Z. H.	-	The effect of temperature and pH on the activity of FVIIa: implications for the efficacy of high-dose FVIIa in hypothermic and acidotic patients
	-	A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function
Menke L. A.	-	Incidence and risk factors for factor VIII antibodies in mild hemophilia A
Mensah P.	-	Bleeding in patients with factor XII deficiency may relate to concomitant platelet function disorders if von Willebrand's disease is excluded
	-	Peri-operative bleeding in patients with Pseudomyxoma peritonei appears to relate to trauma induced hypofibrinogenemia
Mensink E.	-	The Nijmegen low-titer factor VIII inhibitor assay: a highly sensitive assay for the detection of low-titer factor VIII inhibitors
	-	Evaluation of the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic approach to determine Glanzmann Thrombasthenia in blood platelet lysates
Mera V.	-	Early developments of the post-thrombotic syndrome in overweight and obese patients
	-	Weight changes after acute deep venous throbosis: a prospective observational study
	-	Determinants of delayed thrombus regression after deep vein thrombosis of the lower limbs: a prospective cohort study
Mercier E.	-	Antiphospholipid/antiprotein antibodies and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study
	-	Anti-protein Z antibodies in women with abnormal pregnancies
Merieux Y.	-	In vitro flow cytometry and functional testing of fresh and cryopreserved platelets
Merli G.	-	A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
	-	A risk assessment model for identifying medical patients who should receive thromboprophylaxis
	-	Secondary prevention of venous thromboembolic events (VTE) in patients with active malignancy: a randomized study of enoxaparin sodium alone vs. initial enoxaparin sodium followed by warfarin for a 180-day period
Merlini P. A.	-	Lack of association between the annexin V gene -1C®T polymorphism and acute myocardial infarction in 150 young Italian women
Merlini P.	-	Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction
Meroni P. L.	-	Hemostasis and inflammation in advanced heart failure and after successful heart transplantation
Merricks E. P.	-	The development of pro-hemostatic lyophilized platelets with minimized risk for intravascular coagulation
	-	Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
Merrill J. T.	-	IgG autoantibodies to OxLig-1/B2GPI complex are associated with arterial thrombosis in patients with anti-phospholipid syndrome
	-	IgG antiphosphatidylserine and anti-b2GPI are better predictors of arterial and venous thrombosis than anticardiolipin antibodies in antiphospholipid syndrome
Merrill-Skoloff G.	-	Opposing effects of P-selectin and PECAM-1 on arterial thrombus growth and stability in vivo
Mertens K.	-	Cleavage of factor VIII heavy chain by thrombin increases the affinity for low-density lipoprotein receptor-related protein (LRP)
	-	Exposure of a binding site for the low-density lipoprotein receptor-related protein (LRP) upon activation of factor V
	-	A mouse model for inhibitor development in mild hemophilia A
Mertens K.	-	Factor VIII molecular interactions
	-	Factor VIII – factor IX interactions probed by chimeric factor VIII/V variants: complex assembly and cofactor function involve different residues within the A3 domain region 1803–1818
Mertens K.	-	Role of factor IX surface loop 342–347 in factor VIII-mediated enhancement of catalytic activity
	-	Molecular events involved in factor IXa stimulation by the factor VIII A2 domain
Merviè J.	-	Safety of the transfer of patients on anticoagulant therapy from hospital anticoagulant clinics to general practitioners using a computer-decision support
Merx K.	-	Relation of changes in D-dimer and other coagulation markers with changes in Marder Score after treatment of acute venous thrombosis with the low molecular weight heparin Certoparin or unfractionated heparin
Merz M.	-	Evaluation of an automated von Willebrand factor (vWF) antigen assay
	-	Investigation of plasma related influence factors of a new protein S activity assay (protein S Ac^®)
Merz M.	-	Performance of a new PT Calibrator
Meschengieser S. S.	-	Virtual decrease of von Willebrand Factor-cleaving protease (ADAMTS13) after infusion of desmopressin (DDAVP)
	-	Flow cytometry analysis of platelet activation throughout normal gestation and puerperium
	-	Low molecular weight heparin (LMWH) in pregnant women with mechanical prosthetic heart valves (MPHV)
Meschengieser S.	-	Behaviour of the protein C (PC)/protein S (PS) ratio in patients with thrombosis
Meschengieser S. S.	-	Anti-phospholipid antibodies and hyperhomocysteinemia: response to therapy with folic acid
	-	Incidence of major hemorrhages related to surgery in type 1 von Willebrand's disease patients
	-	Anticoagulation therapy outcome in children after extracardiac conduit Fontan operation
	-	Platelet von Willebrand factor antigen (VWF:Ag-i) in patients with mucocutaneous bleeding tendency and normal von Willebrand factor (VWF) plasma levels
	-	Prevalence of haemostatic and fibrinolytic abnormalities in women with unexplained embryofetal losses and vascular obstetric complications
	-	Cysteine–homocysteine ratio in patients with C677T mutation of the MTHFR gene
Meseguer E.	-	Hypercoagulability in cerebrovascular disease (CD): factor V Leiden, prothrombin G20210A and MTHFR C677T mutations and polymorphism in the annexin V kozac sequence
	-	TNF-alpha promoter polymorphisms (-238 and -308) in patients with cerebrovascular disease
Messenger S.	-	Analysis of storage and regulated secretion of three human variants of von Willebrand factor provides new insights into von Willebrand's disease
Messenger S. L.	-	In vitro expression of 4 novel mutations identified in type 1 von Willebrand disease patients
Messenger S. L.	-	A novel type 1 von Willebrand disease causing mutation (S49R) in the von Willebrand factor pro-peptide that affects von Willebrand factor multimerization and secretion
Messmore H. L.	-	Serine proteases–mediated serotonin release and its inhibition by argatroban and other direct thrombin inhibitors: Implications in the control of thrombogenesis
	-	Activated clotting time guided dosage optimization of a low molecular weight heparin (tinzaparin) for surgical and interventional indications
	-	Heparin-induced anti-platelet antibodies in very low birth-weight infants
	-	Effectiveness of polybrene neutralization of heparin and low-molecular weight heparin in plasma
	-	A postoperative platelet count threshold contributes to an earlier diagnosis of heparin-induced thrombocytopenia and improved platelet recovery in cardiac surgery patients. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) study
	-	Prevalence of anti-Erythropoietin antibodies in end stage renal disease patients treated with recombinant Erythropoietin
Messmore H.	-	Argatroban anticoagulation inhibits thrombin generation and its rebound during percutaneous interventional procedures
Mesters R. M.	-	Overexpression of basic fibroblast growth factor (bFGF) in the bone marrow of patients with acute myeloid leukemia: a potential role for bFGF as an autocrine growth factor
	-	Amino acid sequences in factor Xa that bind prothrombin and factor Va
	-	Amino acid sequences in human prothrombin that interact with factor Xa and factor Va
Metge S.	-	Acquired protein S deficiency in HIV-infected patients is corrected under HAART
Metson-Scott T.	-	Sequential adhesion of platelets and then leukocytes from blood flowing over collagen in simple laminar and disturbed flow
Metz D.	-	Increasing the dosage of aspirin before percutaneaous coronary intervention: is there any effect in aspirin resistant patients? A randomized study
Metzner H. J.	-	Comparison of von Willebrand factor activities measured by ristocetin cofactor assay and two different VWF-collagen-binding-assays in VWF/FVIII-concentrates
	-	Determination of High-Molecular-Weight von Willebrand factor multimers and their impact on specific VWF-activities in VWF/FVIII-concentrates
Meugnier E.	-	Ischemia induces early and enhanced expression of a new transcription factor (6A3-5) in human and rat kidney vascular smooth muscle cells
Meuleman D. G.	-	Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
	-	Potential reversal agents for the long-acting pentasaccharide idraparinux
	-	Soluble tissue factor released by cultured human umbilical vein endothelial cells is microparticle-associated and triggers thrombus formation in vivo
Meyer D.	-	Increased metastatic potential of tumor cells in von Willebrand factor (VWF)-deficient mice
	-	Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
	-	An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
Meyer T.	-	Tissue factor is present in platelet-derived microparticles from healthy donors
Meyer D.	-	Type-2 mutations within the A1 domain of Von Willebrand Factor: how protein conformation modulates binding to platelet membrane GPIba
Meyer D.	-	Sensitivity and specificity of PFA-100® vs. bleeding time in the diagnosis of type 1 von Willebrand disease (VWD)
	-	An in vivo model to study von Willebrand factor (VWF) clearance: fundamental aspects and application to the Arg1205His Vicenza mutation
	-	Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
Meyer T. V.	-	Platelet microparticles carry CD40 ligand and up-regulate TF and VEGF in endothelial and melanoma cells: possible role in angiogenesis and metastasis
	-	Platelet CD40L and CD40 enhance tumor cell-induced coagulopathy and experimental metastasis
Meyer D.	-	Evaluation of a new quantitative, rapid test (VWF-LIA) for the diagnosis of type 1 VWD
	-	Stability of 19 mutated recombinant von Willebrand factor to von Willebrand factor-cleaving protease (ADAMTS13)
	-	Identification of seven new candidate mutations of ADAMTS13 gene in four French families related to congenital thrombotic thrombocytopenic purpura
Meyer T. V.	-	Bovine heparin results in higher generation of functional anti-heparin-PF4 antibodies than porcine heparin following coronary artery bypass surgery
Meyer D.	-	The coordinated transcription of genes encoding regulators of cell cycle progression revealed by expression profiling upon calcium ionophore A23187 treatment of B lymphoblasts from a patient with Scott syndrome
Meyer M. W.	-	Expression of Plasminogen activator inhibitor-1 (PAI-1) mRNA in human ciliary processes and determination of PAI-1 in human aqueous humor
Meyer D.	-	Identification and expression of the first type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene
	-	Type 2N von Willebrand disease due to compound heterozygosity for the frequent R854Q type 2N mutation and a new R763G mutation abolishing the cleavage of von Willebrand factor propeptide
	-	Mutation of cysteines 1157 or 1234 located within the D3 domain of Von Willebrand Factor causes intracellular retention of high molecular weight multimers
Meyer T. V.	-	Identification of a tissue factor ortholog in zebrafish, a potential new animal model of hemostasis and cancer
Meyer Reigner S. C.	-	Thrombin binding to GPIba induces platelet adhesion, aggregation and fibrin clot retraction supported by resting a Iibb 3 interaction with polymerized fibrin
Meyers F. A.	-	Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism
Mezzano D.	-	Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
Mezzano D.	-	Lack of association of platelet membrane glycoprotein polymorphisms with the clinical expression of von Willebrand disease type 1
	-	Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
Mezzasoma A. M.	-	Platelet-derived nitric oxide (NO) is suppressed by hyperhomocysteinemia: a possible prothrombotic effect
Miñano A.	-	Detection of conformational transformation of antithrombin in blood by crossed immunoelectrophoresis: new application for a classical method. Effect of temperature in plasmatic antithrombin; role in senescence of antithrombin and thrombosis
	-	Analysis of the HPS-1 gene in patients with single platelet dense-granule deficiency and mild bleeding diathesis
	-	Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
Miao H. Z.	-	Genetic modifications that increase factor VIII secretion in vitro and in vivo
Miao H.	-	The mutation Ser2117Leu, in the second hydrophobic spike of the factor V C2 domain, increases phospholipid affinity and specific activity
Miccio M.	-	Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
Micelli M.	-	Identification of a dysfibrinogenemia characterized by marked resistance to fibrinolysis in an asymptomatic woman
Michaeli Y.	-	Mechanisms for acquired activated Protein C resistance in cancer patients
Michaelides K.	-	Glycoprotein IX Asn45Ser: an ancestral mutation causing Bernard–Soulier syndrome in Europeans?
Michaux G.	-	Analysis of storage and regulated secretion of three human variants of von Willebrand factor provides new insights into von Willebrand's disease
Michel J. B.	-	Protease-nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells
Michel J.-B.	-	Metalloproteinase 9 and plasmin as secreted markers of complicated atherosclerotic plaques
Michel J. B.	-	Pericellular plasmin induces smooth muscle cell anoikis
Michel J.B.	-	Thrombin regulates the expression of its cellular inhibitor protease nexin-1 in smooth muscle cells
Michel J.	-	Smooth muscle cell recolonization of the aneurysmal thrombus is prevented by storage of leukocyte elastase in fibrin matrix
Michelson A. D.	-	GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention
Michelucci A.	-	Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Michl R.	-	Tissue factor stimulates migration by activation of the mitogen-activated proteinkinase p38 and the GTPase Rac1
Micó M. L.	-	Circulating activated protein C in Behcet's disease and risk of thrombosis
Middeldorp S.	-	Risk assessment of venous thromboembolism in pregnant women with factor V Leiden, prothrombin 20210 A mutation, elevated factor VIII levels or mild hyperhomocystinaemia
	-	Absolute risk of venous thromboembolism (VTE) associated with a single or combined thrombophilic disorder. Preliminary results of a family cohort study
Middeldorp S.	-	The risk of pregnancy complications in women from families with thrombophilic defects
Middeldorp S.	-	Increased risk for venous thromboembolism and myocardial infarction in family members of patients with prothrombin 20210 A mutation
	-	The optimal duration of treatment with vitamin K antagonists in patients with a first episode of venous thromboembolism: a decision analytic approach
	-	Oral contraceptives decrease the sensitivity of plasma for the anticoagulant activity of activated protein C (APC) by decreasing plasma glucosylceramide (GlcCer) level
	-	Patients' valuation of outcomes after venous thromboembolism
	-	The balance between the benefits and risks of treatment with vitamin K antagonists as perceived by patients
Middledorp S.	-	Venous and arterial thromboembolic risk in first degree family members of patients with elevated plasma levels of clotting factor VIII:c
	-	Absolute risk of venous and arterial thromboembolism associated with mild hyperhomocysteinemia. Preliminary results of a family cohort study
Middleton L.	-	Disease genetics and recent advances in pharmacogenetics
Miesbach W.	-	ADAMTS-13 activity and corresponding inhibitor titers during plasma exchange therapy in 13 pts with Thrombotic Thromobcytopenic Purpura (TTP)
Miesbach W.	-	Clinical manifestations of the antiphospholipid syndrome in patients with highly elevated anticardiolipin antibodies
	-	IgM-anticardiolipin – marker of a previous thrombosis?
	-	The antiphospholipid syndrome and cerebral manifestations
Miesbach W.	-	Mild ADAMTS-13 deficiency in patients with ischemic stroke
Migaud-Fressart M.	-	The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene is associated with levels of soluble plasma EPCR
	-	The biphasic waveform of APTT optical clot formation profile is related with the activation of FVII but not with ISTH DIC score or classical coagulation activation parameters
Migliacci R.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Mihailov D.	-	Evaluation of the rFVIIa efficacy in children's haemorrhages of different etiology
Mihalis E.	-	Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Mihaly J.	-	Urokinase receptor (uPAR) regulates integrin redistribution during initial vascular endothelial growth factor (VEGF)-induced endothelial cell migration
Mihout B.	-	Protein C promoter polymorphisms are potential additional risk factors for cerebral venous thrombosis
Mika S.	-	Hypercoagulation and elevated blood pressure induced by phosphatidylserine/phosphatidylcholine microvesicles in pregnant mice can be suppressed by heparin and annexin V
Mikac U.	-	Shear rate of plasma flow and fibrin specificity of thrombolytic agent promote thrombolysis of nonretracted and retracted whole blood clots – a MRI study in vitro
Mikhailenko L.	-	Influence of peloidotherapy on hemostasis, cytokines productions and lymphocyte-platelet adhesion
Mikkelsson J.	-	Kozak sequence polymorphism of the platelet glycoprotein Ibalpha gene and Thr789Ala polymorphism of the von Willebrand factor gene in fatal CAD
	-	Relation of prothrombotic platelet polymorphisms to the first manifestation of Coronary Artery Disease in middle-aged males
Mikovic D.	-	The FV Leiden, FII G20210A and MTHFR C677T mutations in healthy and thrombophilic Yugoslav population
Miles L.A.	-	Regulation of plasminogen gene expression by nerve growth factor (NGF)
Miletti S.	-	Cytokine gene expression and production in human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives
Milheiro M. J.	-	Temporary discontinuation of oral anti-coagulants in oncologic patients with mechanical heart valves
Milijic P.	-	Premature atherosclerosis in adult growth hormone deficiency: interaction of fibrinolytic and metabolic factors
Milijic D.	-	Premature atherosclerosis in adult growth hormone deficiency: interaction of fibrinolytic and metabolic factors
Millanvoye Van Brussel E.	-	Thrombomodulin regulates activity, localization and expression of nitric oxide synthase inhuman umbilical vein endothelial cells (HUVECs)
Millar C. M.	-	Combined modality inhibitor eradication in a patient with mild hemophilia A and comparison of methods of inhibitor monitoring
Millar C. M.	-	Increased VWF antigen clearance in partial quantitative von Willebrand factor deficiency and reporting of a familial tendency
Miller G. J.	-	Persistent biochemical hypercoagulability and risk of death from cancer in middle-aged men
Miller C. H.	-	Platelet aggregation and ATP release in whole blood for diagnosis of bleeding disorders
Miller B.	-	Factor VIII pharmacokinetics in young boys with hemophilia: novel measures for prophylaxis dosing
Miller E.	-	Equivalence of venous and capillary INR values determined with the new CoaguChek^® PT.S-test on the CoaguChek^® S system
Miller R. S.	-	Occurrence and management of abciximab induced pseudothrombocytopenia
Miller C. H.	-	Association of plasma homocysteine, serum folate, and red-blood cell folate with venous thromboembolism in American whites and blacks: the GATE study
Miller C. H.	-	Treatment and management of women with bleeding disorders and menorrhagia (WBDM) study: study design and characteristics of women enrolled
Miller E.	-	Performance evaluation of the new CoaguChek^® PT.S-test on the CoaguChek^® S system
Millet L.	-	Thrombolysis induced by streptokinase or recombinant plasminogen activator (rt-PA) is improved by SSR182289A, a direct orally active thrombin inhibitor, in rabbit models of thrombosis
Milne M.	-	Improving the quality of INR determination in the anticoagulation clinic
Mimuro J.	-	Neonatal injection of human factor VIII induces immune tolerance in murine hemophilia A
Minar E.	-	Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
	-	Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
	-	High dose of atorvastatin does not effect levels of plasma tissue factor in patients with coronary artery disease
	-	Assessing the risk of recurrence in patients with a first spontaneous venous thromboembolism by use of D-dimer
	-	C-reactive protein in patients with venous thromboembolism
Minardi V.	-	Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
	-	Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
	-	Chemotherapy-induced activation of hemostasis: the role of d-dimer
Mineeva N.	-	Red blood cells ABH and Lewis antigens prevalence in von Willebrand disease patients
Mineo T. C.	-	Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Minh-Muzeaux S.	-	d-dimer levels: a prognostic value in patients with chronic atrial fibrillation
Minotti C.	-	Thrombophilic screening in patients with paroxysmal nocturnal hemoglobinuria
Minullina I.	-	Lupus anticoagulant as marker of immune system dysfunction in patients with multiple sclerosis
Mira Y.	-	The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene is associated with levels of soluble plasma EPCR
	-	The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene reduces the risk of venous thromboembolism in carriers of the factor V Leiden mutation
Miraglia E.	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Miron M. J.	-	Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Mirsamatova G.	-	The influence of change of cell surfaces on aggregation function of blood
Mirza D.	-	Haemostasis in surgery: Is there a role of haemorrhage control with rVlla in patients with liver disease?
Miscevic N.	-	Recombinant FVIIa: correction of thrombocytopenic defects in whole blood clotting model
	-	Assessing rFVIIa coumadin reversal effect with whole blood coagulation analyzer
Mischke R.	-	A mutation leading to a stop codon in the FVIII gene is the cause of severe canine Hemophilia A
Mismetti P.	-	Predictive factors of cancer discovery after deep-vein thrombosis: a 8-years follow-up study
Mismetti P.	-	A meta-analysis on the benefit-to-risk ratio of Vitamin K antagonists (VKA) in the prevention of venous thromboembolism in major orthopedic surgery
Mismetti P.	-	Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis
	-	Factors predicting venous thrombotic complications after superficial–vein thrombosis
Mismetti P.	-	Differences between predictive factors for PE and DVT recurrences: results from 5 randomized trials
	-	Risk factors of major hemorrhages during treatment of acute DVT: results from 5 randomized trials
Mismetti P.	-	Clinical experience with optional cava filters
Misra S.	-	Combined mechanical and pharmacologic thrombolysis for ilio-femoral deep venous thrombosis. Single center short-term outcomes
Misra N.	-	Perturbations in the blood T-cell repertoire of inhibitor-positive patients with severe hemophilia A
Misra N.	-	Kinetics of hydrolysis by anti-FVIII antibodies in hemophilia A
Misselwitz F.	-	Reviparin normalizes tissue factor pathway activation in patients with lower limb immobilization and is not associated with heparin antibody production
	-	Phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis
	-	Lower limb trauma is associated with a moderate risk of thrombosis caused by sustained release of tissue factor despite early functional mobilization
	-	Unfractionated heparin, but not a low-molecular-weight heparin (Clivarin), mediates differential generation of anti-heparin-PF4 antibodies in orthopedic surgery patients: Pathophysiologic and pharmacologic implications
Mistry N.	-	Mechanotransduction through glycoprotein Iba induces a unique series of morphologic changes in translocating platelets
	-	Cytoskeletal regulation of the adhesive interactions between the platelet GPIb/V/IX receptor and von Willebrand factor
Mitchell L.	-	A case series of 72 neonates with renal vein thrombosis: data from 1 to 800-No-Clots registry
	-	Ex vivo thrombin generation capacity in pediatric patients receiving Tinzaparin
Mitchell D.	-	A dose-finding study of Tinzaparin in pediatric patients
Mitchell L.	-	A dose-finding study of Tinzaparin in pediatric patients
	-	Enhanced in vivo platelet activation in patients with peripheral arterial disease, and differences between intermittent claudication and critical limb ischemia
	-	Reversal of warfarin or low molecular weight heparin (LMWH) using subcutaneous unfractionated heparin (UFH) in pediatric outpatients with an ongoing high risk for thrombosis and requiring invasive procedures: a prospective cohort study of 146 children
	-	Poor correlation between aPTT, anti-Xa levels and heparin dose in children receiving therapeutic doses of unfractionated heparin
Mitchell V.	-	The effects of folic acid supplements on coagulation status in pregnancy
Mitchell D.	-	A pharmacokinetic study of tinzaparin in pediatric patients
Mitchell L.	-	A pharmacokinetic study of tinzaparin in pediatric patients
Mitchell L. G.	-	The effect of age on plasmin generation in the presence of fibrin monomer on endothelium
Mitchell M. J.	-	Different risk of pulmonary embolism development in patients with deep-vein thrombosis from North-Western Russia having either factor V Leiden or prothrombin G20210A mutation
Mitchell W. B.	-	Biochemical, immunologic and computer-modeling evidence localizing the mAb 7E3 Epitope on aIIbb3
Mitchell L.	-	Central venous line-related thrombotic events in children: association with duration of line placement, type, size, and location
	-	Very low dose warfarin for primary and secondary prophylaxis in children: a prospective cohort study of 20 children
	-	Reversal of low molecular weight heparin (LMWH) prior to invasive procedures using subcutaneous unfractionated heparin in children with an ongoing high risk for thrombosis
Miteva M. A.	-	Theoretical and experimental investigation of the D2194G subsitution in the C2 domain of coagulation factor V
Miteva M.	-	Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized
Mitra N.	-	Activation of the platelet integrin aIIbb3 by thermodynamic modulation of transmembrane helix associations
Mitterer A.	-	Development of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM)
Miyagi Y.	-	Tissue factor pathway inhibitor-2 (TFPI-2) binds the complement and kinin binding protein gC1qR/p33 (gC1qR)
Miyamori I.	-	Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family
Miyamoto T.	-	Ultrasound improves myocardial perfusion in a canine model of myocardial infarction
Miyata T.	-	D1596-R1668 of von Willebrand factor is a minimal region recognized as a specific substrate for ADAMTS-13
Miyata S.	-	Blood coagulation during mural throbogenesis under whole blood flow conditions with high shear rates
Miyata T.	-	Assessment of diagnostic procedures, ratio method and posterior probability method, for protein C deficiency using protein C and antithrombin activities
Miyata S.	-	Mural thrombus generation in classic hemophilia under whole blood flow conditions
Miyata T.	-	Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease
Miyata S.	-	Successful argatroban-anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II
Miyata K.	-	Anti-thrombotic effect of YM337 on carotid artery thrombi induced in squirrel monkeys by electrical stimulation
Miyata T.	-	Mutations of ADAMTS13 gene in four Japanese families with Upshaw–Schulman syndrome
Mizuno H.	-	Characterization and preliminary crystallographic studies of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus
	-	Effect of Mg(II) ion on the interaction of factor IX with phospholipid membrane
Mizuno H.	-	Crystal structure of a disintegrin from snake venom containing a cell adhesion recognition sequence RGD
Mizuno T.	-	Mural thrombus generation in classic hemophilia under whole blood flow conditions
Mizuno T.	-	Blood coagulation during mural throbogenesis under whole blood flow conditions with high shear rates
Mizutani T.	-	Is an antithrombin substance (aFIIa) more hemorrhagic compared with an anti-factor Xa (aFXa) aent?: Differential inhibitory effects of these two agents against platelet activation
	-	Three novel point mutations that cause severe factor XI deficiency in two unrelated Japanese families
	-	Rituximab reduces anti-phospholipid antibody (APA) titers and improves hypercoagulability in patients with anti-phospholipid syndrome (APS)
Mlekusch I.	-	Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
	-	Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
Moake J.	-	Peptides from the C-terminal regions of ADAMTS-13 specifically block cleavage of ultra-large von Willebrand factor multimers on the endothelial surface under flow
Moal V.	-	Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration
Moatti D.	-	Induction of fractalkine by endothelial cells under shear stress
Modesto J. C. A.	-	Platelet responses mediated by venom snake metalloproteases (MP1 and MP3)
Moerland M.	-	A novel method to accurately measure collagen/serotonin-induced platelet aggregation by whole blood impedance aggregometry in humans
Moessmer G.	-	Angiotensinogen gene polymorphisms Met235Thr, G(-6)A, and A(-20)C in women with a history of pre-eclampsia or HELLP syndrome – preliminary results
Moffat K. A.	-	Variability of clinical laboratory practice in testing for disorders of platelet function: results of a NASCOLA survey
Mogami H.	-	Plasminogen activator inhibitor-1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via a vb 5 integrin
Moghaddam M.	-	Prevalence of anti-Erythropoietin antibodies in end stage renal disease patients treated with recombinant Erythropoietin
Mogielnicki A.	-	Effect of angiotensin II and their metabolites on hemostasis in rats
Mogielnicki A.	-	Thrombolytic effect of AT1 receptor antagonists – losartan and its metabolite EXP 3174 in rat
Mohammadpour H. A.	-	Reducing body iron stores lowers inflammatory cytokine levels in atherosclerotic claudicants
Mohanty D.	-	Glanzmanns thrombasthenia in Indians – how different it is from other ethnic groups
	-	Direct detection of factor IX gene deletions in Indian hemphiliacs by multiplex PCR
Mohanty D.	-	Diagnosis of neonatal alloimmune thrombocytopenic purpura (NAITP) by genotyping and human platelet antigen frequency in the Indian population
	-	Burden of von Willebrand disease in India
Moheb M.	-	Isolated thrombocytopenia as a preliminary feature of antiphospholipid syndrome in patients with chronic liver disease
Mohn A. C.	-	Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after major abdominal surgery: the FAME study
Mohr G.	-	Towards the development of a recombinant von Willebrand factor-cleaving protease (ADAMTS-13)
Mohr J. P.	-	Thrombin generation after ischemic stroke: the hemostatic system activation study (HAS)
Mohri M.	-	Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
Moia M.	-	Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
	-	Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
	-	A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project
	-	A study of 130 Italian patients on anti-coagulant treatment: how variant alleles of gene CYP2C9 influence requirement dose of warfarin during the induction period of treatment
	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Moir E.	-	Thrombolytic properties of normal human neutrophils
Mol De B. A.	-	Optimal intensity of oral anti-coagulant therapy in patients with mechanical heart valves
Molina J. F.	-	Use of a decision-making system based on the Fuzzy sets theory applied to the routine of results' release in the haemostasis laboratory: how to do it better and quicker
Molinotti M.	-	Perioperative management with low molecular weight heparin (LMWH) of patients (pts) on long-term oral anticoagulant therapy (OAT) undergoing major surgery: a multicenter prospective observational study
Moliterno D. J.	-	Issues in monitoring direct thrombin inhibitors: comparison of a new, rapid Ecarin Clotting Time (ECT) test to activated clotting time (ACT) and anti-IIa assays
Moliterno D.	-	The Rapidpoint™ ENOX point-of-care test has strong correlation with anti-Xa levels for detecting the anti-coagulant effects of enoxaparin
Moliterno D.	-	Rapid point-of-care assessment of enoxaparin activity during percutaneous coronary interventions: the ELECT study
Moll S.	-	Acquired von Willebrand's disease not responding to Rituximab
	-	Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
Mollica L.	-	Human endothelial cell protein C receptor (EPCR) expression: role of proximal and distal 5'-gene regulatory elements
Molostvov G.	-	The effects of thalidomide analogues on VEGF and IL-6 production in myeloma and endothelial cell cocultures
Momi S.	-	Platelet depletion abolishes eosinophil recruitment to the lungs and tissue remodelling in an allergic asthma model in mice
	-	LPS induced MMPs release in mice: role of platelets and inhibition by NCX4016 (nitroaspirin)
Monagle P.	-	Anti-coagulation clinics for children achieve improved warfarin management
	-	Venous thrombosis in children
Monagle P.	-	Arterial thromboembolic disease in infants and children
Monagle P.	-	Thrombolytic therapy with tissue plasminogen activator (tPA), analysis of safety and outcome in children
Monagle P.	-	Reference ranges for hemostatic parameters in children
	-	Prospective cohort study of paediatric venous thrombosis
Monahan K.	-	Warfarin loading with a 5-mg daily dose for the first 3 days of treatment is safe and effective for the management of patients with venous thrombosis
Monahan P.	-	Novel factor V mutations in three separate families resulting in factor V deficiency and bleeding
Monasterio A.	-	Proteolytic pattern in advanced atherosclerotic human lesions: relation to vascular bed, plaque features, and cardiovascular risk factors
	-	Pravastatin modulates the cytokine-induced endothelial expression of PGE2: A novel anti-inflammatory mechanism of cholesterol-lowering drugs
	-	Circulating prostaglandin E2 is associated with high risk of coronary heart disease in asymptomatic subjects: a novel inflammatory marker of subclinical atherosclerosis
	-	The endothelial expression of pai-1 by Angiotensin II is dependent on the 4 g/5 g polymorphism: clinical and therapeutic implications
Mondala T.	-	Platelet integrin a2 SNP 807C is a predictor of bleeding in Von Willebrand Disease (VWD) type 1
Monden M. M.	-	The possible role of calpain in cancer mediated vascular endothelial cell (vEC) retraction
Mondorf W.	-	Evaluation of a ‘handheld’ communicator based electronic system for documentation of hemophilia A and B therapy in home-care settings
Monesi M.	-	Safety, efficiency and dose saving of continuous infusion modality of protein C concentrate in the management of a protein deficient patient submitted to orthopedic surgical procedure
Mongkolwongroj P.	-	Detection of the factor XIIIA Val34Leu polymorphism in Thais
Monraats P. S.	-	Prescribing anticoagulant prophylaxis in patients with hematological or solid tumor malignancies and central vein catheters: a nationwide survey
Monrad E. S.	-	Is aspirin resistance more common in Black patients?
	-	Factor VII levels, coronary artery disease, and MI
Monreal M.	-	A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Monreal M.	-	Management and outcome of patients with venous thromboembolism: a prospective registry including over 5000 consecutive patients
Monreal M.	-	Interactive session: special patient cases
	-	Non-invasive detection of proximal DVT using bilateral compression ultrasound: methodology for the EXCLAIM study
	-	Extended thromboprophylaxis with enoxaparin in acutely ill medical patients with prolonged periods of immobilisation: the EXCLAIM study
Monroe D. M.	-	Platelet P2Y12 inhibition decreases GPVI stimulated increases in thrombin generation on activated platelets
	-	A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function
	-	Calcium ionophore A23187 and convulxin increase Xa generation in a cell-based model of hemostasis
	-	The effect of temperature and pH on the activity of FVIIa: implications for the efficacy of high-dose FVIIa in hypothermic and acidotic patients
Monroe D.M.	-	Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system
Monroe D. M.	-	Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of hemophilia
Montalescot G.	-	Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
	-	Combination therapy with low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Montaruli B.	-	Anti-protein S antibodies in patients with venous and/or arterial thrombosis
	-	Prolonged APTT children undergoing elective tonsillectomy
Monteagudo J.	-	Comparison of hemorrhagic symptoms in obligatory carriers of type 1 and type 3 von willebrand disease (VWD): results from a collaborative, international, multicenter study
	-	Clinical presentation of type 1 von Willebrand disease (VWD) in obligatory carriers: final results from a collaborative, international, multicenter study
	-	Effect of antiphospholipid antibodies in the activation of the contact complex: importance in the obstetric complications of the antipospholipid syndrome
	-	Polymorphisms of platelet glycoproteins Ib-a and Ia/IIa: relationship with early arteriosclerosis and arterial thrombosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus
Montefusco M. C.	-	Allelic heterogeneity of severe factor V deficiency: doubling of the mutational spectrum of the factor V gene, and expression of the identified missense mutations
Monteiro F.	-	Association of MTHFR and ACE gene polymorphisms in reflux associated with renal damage
	-	A different view on the inflammatory bowel disease – the role of adhesion molecules and angiogenic growth factors
Montequin J. F.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Montequín J. F.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Montgomery R. R.	-	Assay of the von Willebrand factor propeptide in patients with type 1 von Willebrand disease (VWD) and the identification of patients with a S2179F mutation in the D4 region of von Willebrand factor
	-	Type 2 M von Willebrand disease due to linked P1266Q and V1279I substitutions in the von Willebrand factor A1 domain
	-	Oral factor VIII concentrate for immune tolerance induction: preliminary study of safety in a high responder inhibitor patient
Montgomery R. R.	-	Biosynthesis and assembly of FVIII–vWF complex
Montgomery R. R.	-	The sorting signal for von Willebrand factor (vWF) granular storage lies within the first 140 amino acids of the D2 domain of the VWF propeptide (VWFpp)
	-	Cloning and expression of full-length recombinant porcine von Willebrand factor
	-	Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
	-	A case of compound type 2N/type 1 von Willebrand disease linked to a novel von Willebrand factor exon 18 mutation A2311G encoding for Met 771 val
	-	A transgenic mouse model demonstrates the efficacy of Factor VIII ectopically expressed in platelets for Haemophilia A treatment
Montserrat I.	-	Self-management of oral anti-coagulation reduces the incidence of complications: preliminary results of the ACOA clinical trial
Moody A.	-	Recognized and unrecognized clinical venous thromboembolism (VTE) after acute ischemic stroke (AIS): a prospective study using magnetic resonance direct thrombus imaging (MRDTI)
Moody A. R.	-	Magnetic Resonance Direct Thrombus Imaging
Moody A.	-	Performance characteristics of the VIDAS and IL test d-dimer (d-d) assays as exclusionary tests for venous thromboembolism (VTE) after acute ischemic stroke (AIS)
	-	The relationship between acute ischemic stroke (AIS) per se and plasma D-D (D-D) levels
	-	The relationship between plasma D-dimers (D-d) and thrombus load in patients with deep vein thrombosis (DVT) after acute ischaemic stroke (AIS): a prospective study using magnetic resonance direct thrombus imaging (MRDTI)
Moon D. G.	-	Statin regulation of extrinsic thrombin generation
Moons K. G. M.	-	Coronary risk prediction and the role of C-reactive protein
Moore N. R.	-	The role of TAFIa in relation to serpin inhibitors of fibrinolysis
Moore G. W.	-	Use of specific reference ranges for equal volume mixing studies in lupus anticoagulant assays
Moore J. C.	-	A systematic analysis of the effects of a thrombin-specific inhibitor, argatroban in HIT
Moore N. R.	-	The C-terminus of a ₂-anti-plasmin: effect on fibrinolysis
	-	TAFI is cross-linked by its activation peptide to sites on fibrin(ogen) distinct from other inhibitors of fibrinolysis
Moore C.	-	Perioperative management of patients on oral anti-coagulants: a decision-analysis
Mooser V.	-	Disease genetics and recent advances in pharmacogenetics
Morais S.	-	Glanzmann thrombasthenia: a study of two Portuguese families and identification of a new homozygous C insertion in exon 10 of the GPIIIa
Morales M.	-	Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
	-	Lack of association of platelet membrane glycoprotein polymorphisms with the clinical expression of von Willebrand disease type 1
Morales-Anduaga M. E.	-	Lipoprotein (a) polymorphisms in Mexican-Amerindian populations
Moran P.	-	Differential use of variable domains of D3H44 antibody in binding to tissue factor or to an anti-idiotypic antibody
Moran N.	-	Identification of an integrin-associated chloride channel in human platelets
	-	Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
	-	Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
Moran V.	-	Inhibition of platelet secretion-induced neutrophil activation by ELR peptide derivatives
Moran B.	-	Peri-operative bleeding in patients with Pseudomyxoma peritonei appears to relate to trauma induced hypofibrinogenemia
Moran N.	-	Functional modulation of platelet aIIbb3 by its endogenous thiol isomerase activity
Moran P.	-	Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity
Moran R.	-	The measurement and prevalence of antibodies to prothrombin in patients screened for anti-phospholipid syndrome
Moran N.	-	A role for the thiol isomerase activity of a IIbb 3 in receptor clustering
Morand E.	-	The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia
Morange P. E.	-	Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
Morange P.	-	Transmembrane TNFa and wild-type TNFa differently modulate atherosclerotic process in mice
Morange P. E.	-	Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Moratelli S.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Mor-Cohen R.	-	Aging of ancestral mutations causing factor VII deficiency and Dubin–Johnson syndrome in Iranian and Moroccan Jews reflects ancient Jewish migrations
Morcos M.	-	Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
Morel-Kopp M.-C.	-	A prospective randomized trial of anti-platelet therapies in patients with carotid artery disease (preliminary results)
Morel-Kopp M-C.	-	Glycoprotein IX Asn45Ser: an ancestral mutation causing Bernard–Soulier syndrome in Europeans?
Morelli G. A.	-	Relationship of thromboembolism (TE) to subsequent cancer diagnosis: a study in a veteran population
Morelli V. M.	-	A transcobalamin gene polymorphism and the risk of deep venous thrombosis
	-	Factor XIII (FXIII) Val34Leu, His95Arg and G30899A polymorphisms and the risk of deep venous thrombosis
Morelli G. A.	-	Treatment of myelodysplastic syndrome with arsenic trioxide (ATO): response in refractory, transfusion-dependent patients
Morelli V. M.	-	A 23-bp insertion in the EPCR gene and the risk of venous thrombosis
	-	Prothrombin mutation G20210A, and not factor V Leiden, is a significant risk factor for cerebral venous thrombosis in 27 Brazilian patients
Morettini A.	-	Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
Morfini M.	-	Monitoring the pharmacokinetic of inhibitor-bypassing agents with a new thrombin generation assay
	-	In vivo recovery, efficacy and safety of solvent/detergent treated plasma in patients with rare inherited bleeding disorders
Morgan H.	-	Development of bifunctional inhibitors of both platelet aggregation and factor Xa
Morgan T.	-	Factor V Gly2112Asp, a C2-domain variant, is associated with severe deficiency and a bleeding tendency
Morgenstern E.	-	Electron microscopy of thrombasthenic platelets after rFVIIa substitution
	-	Microvesicle and platelet associated tissue factor promote initiation of coagulation
Morgensztern D.	-	Thrombotic thrombocytopenic purpura in a patient with acquired vWF protease (ADAMTS13) deficiency was heralded by variable stimuli and lacked a good correlation between platelet counts and vWF protease levels
Moriguchi S.	-	Localization and activity of ecto-ATP diphosphohydrolase/CD39 in human tissues
Moriki T.	-	Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lanka ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X
Morin S.	-	Variations of INR and Factor VII Level are linked to Cytochrome P450 2C9 genotype
Morini L.	-	Hyperhomocysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease
Morishita E.	-	Rituximab reduces anti-phospholipid antibody (APA) titers and improves hypercoagulability in patients with anti-phospholipid syndrome (APS)
Morishita E.	-	Three novel point mutations that cause severe factor XI deficiency in two unrelated Japanese families
Morishita E.	-	Is an antithrombin substance (aFIIa) more hemorrhagic compared with an anti-factor Xa (aFXa) aent?: Differential inhibitory effects of these two agents against platelet activation
Morita T.	-	A new gene structure of disintegrin family: a subunit of dimeric disintegrin has short coding region
Morita T.	-	Roles of autolytic loop-2 and at Asp⁵⁵⁴ of human prothrombin in the specificity of meizothrombin
	-	Characterization and preliminary crystallographic studies of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus
	-	Usefulness of the prothrombin level measured by the carinactivase-1 method as the parameter of the coagulation activity during chronic warfarin therapy
	-	Effect of Mg(II) ion on the interaction of factor IX with phospholipid membrane
	-	Crystal structure of a disintegrin from snake venom containing a cell adhesion recognition sequence RGD
Moritz M.	-	Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal disease
Morley N.	-	The use of two plasma derived Factor VIII concentrates in type 2 A von Willebrand's disease (VWD)
Mornex J. F.	-	Two electrophoretic fibrinogen variants found in patients with normal coagulation and familial thrombosis
Moroi M.	-	VWF/FVIII concentrate enhances platelet adhesion onto a surface of immobilized collagen under flow conditions
	-	Variation of GPVI levels in platelets: relationship to platelet function at high shear
Moroose G. J. R.	-	Bovine heparin results in higher generation of functional anti-heparin-PF4 antibodies than porcine heparin following coronary artery bypass surgery
Moroose R.	-	Bivalirudin, a direct thrombin inhibitor, in the treatment of heparin-induced thrombocytopenia
Moroz N. A.	-	Development of novel delivery systems of aprotinin
Morra E.	-	VWF:RCo assay implementation on automated coagulometer
Morris K.	-	A comparison of various evacuated blood collection tubes for monitoring warfarin therapy with Innovin
	-	Comparison of normal values for coagulation measurements in a variety of evacuated containers
	-	The suitability of various evacuated blood collection tubes for monitoring heparin
Morris A.	-	The effects of thalidomide analogues on VEGF and IL-6 production in myeloma and endothelial cell cocultures
Morris M. A.	-	Congenital afibrinogenemia: expression and analysis of novel mutations affecting fibrinogen assembly or secretion
Morris A. J.	-	Lipid Phosphate Phosphatase 1 (LPP1) regulates lysophosphatidic acid signaling in platelets
Morris T.	-	A novel method of measuring fibrinopeptide B for the detection of venous thromboembolism
Morrison E. R.	-	Procoagulant changes in human macrophages induced by environmental microparticles [PM₁₀]: a possible pathogenetic mechanism in cardiovascular disease
	-	The phagocytic capacity of human endothelial cells in culture for apoptotic endothelial cells is inhibited by IgG from patients with anti-phospholipid antibodies
Morrison D.	-	Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
Morrison M.	-	Effect of antithrombin on lipopolysaccharide stimulated gene expression by human umbilical vein endothelial cells
Morser J.	-	Activated thrombin–activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs
Morser J. M.	-	Overexpression of PAI-1 prevents abdominal aortic aneurysm development
Morser J.	-	Development of small molecule compounds that inhibit PAI-1 activity in vitro and in vivo
Morton K.M.	-	A randomized, double-blind, placebo-controlled study of the safety and pharmacokinetics of a single dose of recombinant Factor XIII in healthy volunteers
Mosalaei A.	-	Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 von Willebrand factor cleaving protease)
Moscardó A.	-	Insufficient thromboxane A2 inhibition in patients with vascular disease chronically treated with aspirin: implications for platelet function
Moscardó F.	-	Treatment with recombinant activated factor VII of intra-abdominal bleeding associated with disseminated intravascular coagulation caused by septic shock
Moscardó A.	-	Platelet–erythrocyte interactions enhance GPIIbIIIa receptor activation and P-selectin expression during platelet recruitment. These effects are amplified in type I diabetic patients
Mosch G.	-	Safe anti-coagulation with danaparoid in pregnancy and lactation
Moschatsis S.	-	Recombinant factor VIIa restores adhesion and aggregation of a IIbb 3-deficient platelets in vitro
Mosena L.	-	Below-knee elastic compression stockings for prevention of the post–thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study
Mosesson M. W.	-	Altered vascular remodeling in hyperfibrinogenemic mice
Mosher D. F.	-	Expression of recombinant human gla-domainless factor X (gdFX) in the baculovirus: assessing substrate recognition by the intrinsic tenase complex
Mosler K.	-	Severe intracranial hemorrhage in a patient with von Willebrand disease type 2B after being hit by a golf ball
Mosnier L. O.	-	Characterization of the anti-apoptotic effect of activated protein C
	-	Platelet factor 4 up-regulates protein C activation relative to TAFI activation
	-	Complex formation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) with fibrin(ogen)
Mostarda G.	-	Perioperative management with low molecular weight heparin (LMWH) of patients (pts) on long-term oral anticoagulant therapy (OAT) undergoing major surgery: a multicenter prospective observational study
	-	VWF:RCo assay implementation on automated coagulometer
Motloi N. C.	-	Selection and characterization of a novel factor XI inhibiting peptide by using phage display technology
Motoi S.	-	Hypercoagulation and elevated blood pressure induced by phosphatidylserine/phosphatidylcholine microvesicles in pregnant mice can be suppressed by heparin and annexin V
Motto D.	-	ADAMTS13 mutations identified in familial TTP patients result in loss of VWF-cleaving protease activity
Motyka M.	-	Sialic acid and lipid contents of low density lipoprotein in relation to platelet receptor activity
Motyl A.	-	Cerivastatin neither inhibits thrombin generation nor decreases markers of inflamation in patients with APS
Moukhametova L.	-	Fibronolytic properties of two-chain urokinase-type plasminogen activator attached to fibrinogen
Moukhametova L. I.	-	Fibrin specificity of synergistic combined action of staphylokinase and single-chain urokinase-type plasminogen activator on in vitro clot lysis
Moulard M.	-	Immuno-phenotypic platelet characteristics distinguish high vs. low risk patients for thrombosis after stent implantation under thienopyridin plus aspirin treatment
	-	Standardization of circulating endothelial cell enumeration in whole blood
Mountford R.	-	Eleven novel mutations in non-Jewish factor XI deficient kindreds detected by SSCP with heteroduplex analysis followed by sequencing
Mouquet F.	-	Effect of in vivo thrombin inhibition on bFGF-induced angiogenesis in a murine angiogenic model
Moura P.	-	Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
Moura R.	-	Prophylaxis of deep vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin
Moura L.	-	Cost analysis of the treatment of patients with post–thrombotic syndrome in Brazil
Moura Nunes J. F.	-	A sporadic case of gray platelet syndrome
Mouret P.	-	Efficacy and safety of the treatment regimen of melagatran and ximelagatran for prevention of thromboembolic events after total hip or knee replacement: a meta-analysis of 3 randomized, double-blind studies, to evaluate the influence of time and dose
Mousa S. A.	-	Orally active integrin antagonists perturb aIIbb3 integrin conformation
Mousa H.	-	Postpartum levels of activated TAFI (TAFIa) in patient plasmas
Mousa S. A.	-	Dissociation of the JAM-1/avb3 complex followed by signaling through JAM-1 is key to the angiogenic response induced by bFGF: an explanation of the avb3 paradox
Mousa S.	-	Effect of low molecular weight heparin and different heparin molecular weight fractions on the activity of the matrix degrading enzyme aggrecanase: structure-function relationship
	-	Tissue factor pathway inhibitor (TFPI)-mediated inhibitory effect of heparin on endothelial cell tube formation and angiogenesis-induced by FGF-2 or TF/VIIa
Mousa S. A.	-	Comparison of TFPI release of various LMW heparins based on the molecular weight distribution of the LMW heparins and a model describing the TFPI release according to molecular mass
Mousa S.	-	Pharmacodynamic effects of the Low Molecular Weight Heparin (LMWH) tinzaparin in obese, hemodialysis, healthy human subjects on plasma tissue factor pathway inhibitor and nitric oxide
Mousa S.	-	Activated clotting time guided dosage optimization of a low molecular weight heparin (tinzaparin) for surgical and interventional indications
Moya C.	-	Preparation of prothrombin complex concentrate (PCC) at intermediate scale: first experience in Argentina
	-	Development, scale up and characterization of the first regional high purity Factor VIII: the Argentinean experience
Moynard D.	-	Prevalence of methylenetetrahydrofolatereductase (MTHFR) gene polymorphism (C677T) in the Moroccan population
Mpaidas M. J.	-	Patients with adverse pregnancy outcome have lower levels of protein Z and protein S compared to patients with normal pregnancy outcome
	-	Normal pregnancy is associated with decreased protein Z levels in the second and third trimesters compared to early pregnancy
Mseffer Y.	-	The mannometric profile of native arteriovenous fistulas in the Avicenne Hemodialysis Center of Casablanca (preliminary results)
M'Tairag E.	-	Smooth muscle cell recolonization of the aneurysmal thrombus is prevented by storage of leukocyte elastase in fibrin matrix
Muñiz-Diaz E.	-	Transmission electron microscopy of granulocyte inclusions in genetically confirmed MYH9-related disorders
Muñoz X.	-	PROS1 mutations that introduce a premature termination codon explain protein S deficiency by nonsense-mediated mRNA decay
Muñoz B.	-	Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
	-	Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
Muñoz X.	-	Human vitamin K-dependent Gas6 gene: exon–intron structure and identification of allelic variants
Muca-Perja M.	-	Arterio-venous fistula as permanent access for home treatment in children with hemophilia: long-term safety and feasibility
Mueller J.	-	Induction of monocytic tissue factor (TF) expression: an additional mechanism of action of desmopressine acetate (DDAVP)
	-	Gene expression analysis in platelets: use of a PCR-based RNA amplification technique for generating suitable amounts of cDNA
Mueller F.	-	The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Mueller C.	-	Transmembrane TNFa and wild-type TNFa differently modulate atherosclerotic process in mice
Mueller J.	-	Tissue factor (TF) gene expression analysis in blood monocytes
Mueller J.	-	Use of aprotinin as an antidote in activated protein C related bleeding
Mueller C. R.	-	Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Mugnaini C.	-	Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
Mujovic V. M.	-	Platelets–coronary endothelium interaction: focus on L-arginine:NO system
Mukherjee M.	-	Plasma tissue factor pathway inhibitor (TFPI) – A marker of severe coronary atherosclerosis
Mulchandani M.	-	Role of the Type Ia PI 3-kinase p110beta isoform in integrin alpha(IIb)beta(3) bi-directional signaling
Mulder J. W. M.	-	Brain natriuretic peptide (BNP) as a predictor of adverse outcome in patients with pulmonary embolism
Mulder B. J. M.	-	Brain natriuretic peptide (BNP) as a predictor of adverse outcome in patients with pulmonary embolism
Mulder B.	-	PF4 and heparin form high molecular weight complexes that is central to the pathogenesis of Heparin-Induced Thrombocytopenia
Muldowney J.	-	Chronic paclitaxel exposure increases human endothelial expression of plasminogen activator inhibitor-1, tissue-type plasminogen activator and tissue inhibitor of metalloproteinase-1
Muleo G.	-	Clinical data of subjects with Factor V Leiden or G20210A prothrombin mutation: a single institution experience
Müller W.	-	Variation in plasminogen activator inhibitor-1 gene and risk of meningococcal disease
	-	Clinical manifestation and therapy in children with hereditary angioedema (HAE) – a prospective follow up
Müller I.	-	Microvesicle and platelet associated tissue factor promote initiation of coagulation
Müller B.	-	Angiotensinogen gene polymorphisms Met235Thr, G(-6)A, and A(-20)C in women with a history of pre-eclampsia or HELLP syndrome – preliminary results
Müller C.	-	Platelet receptor polymorphisms of glycoprotein (GP) Iba VNTR, GP IIb-IIIa (HPA–1), and GP Ia C807T and the risk of premature myocardial infarction
Muller D. W.	-	Abciximab therapy post elective coronary artery stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin and platelet-monocyte aggregates
Müller W.	-	Favourable course of hemorrhagic complication in early pregnancy of a patient with congenital afibrinogenemia under replacemant therapy
Müller-Esterl W.	-	Proteoglycans dock kininogens to cells and regulate generate bradykinin generation
Mulrow C.	-	Aspirin in primary prevention: at what level of coronary risk?
Mumford A.	-	Functional characterization of recombinant Factor V Liverpool: Ile350Thr, a novel mutation associated with thrombosis
	-	Severe thrombophilia in two brothers due to novel combination of mutations in factor V gene producing quantitative deficiency (Glu119Term) and decreased sensitivity to activated protein C due to a novel glycosylation site (Ile359Thr-FV Liverpool)
Mundt W.	-	Development of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM)
Munnix I.	-	Role of PI 3-kinase in glycoprotein VI-dependent calcium signaling in human platelets
Munnix I. C. A.	-	Interplay of glycoprotein Iba, integrin a2b1 and glycoprotein VI is required for human thrombus formation under flow
Munro R.	-	A comparison of various evacuated blood collection tubes for monitoring warfarin therapy with Innovin
	-	Comparison of normal values for coagulation measurements in a variety of evacuated containers
	-	The suitability of various evacuated blood collection tubes for monitoring heparin
Munster M.	-	HIV associated thrombocytopenia: a 3-year trend analysis at the Johannesburg Hospital
Muntean W.	-	Hemostatic risk factors, metabolic control, and microalbuminuria in diabetes mellitus type 1
	-	Low inhibitor levels allow fast and sufficient thrombin generation in tissue factor-activated cord plasma
	-	Increased von-Willebrand-facor-binding to platelets in neonatal plasma
Murakami Y.	-	Effects of CS-747, a novel P2Y₁₂ receptor antagonist, on cerebral and peripheral arterial occlusive diseases in rats
Muramatsu S.	-	The effect of direct FXa inhibitor and direct thrombin inhibitor on TF induced DIC and venous thrombosis models in anesthetized rat – thrombin inhibitor enhance the platelet consumption in DIC model
Murar J.	-	Experimental studies of anorectic drug cardiovascular toxicity: oral fenfluramine decreases dog platelet serotonin uptake and content, elevates plasma serotonin and causes mild mitral valve regurgitation
Murari M.	-	Clinicopathological findings and response to treatment in childhood and adult immune thrombocytopenic purpura
Murasaki K.	-	The functional profiles of circulating T lymphocytes distinguishes patients with stable angina and unstable angina
Murasaki S.	-	The functional profiles of circulating T lymphocytes distinguishes patients with stable angina and unstable angina
Murasaki K.	-	Insulin enhances human monocyte tissue factor expression induced by activated platelets via phosphatidylinositol-3-kinase signaling pathway
Murasaki S.	-	Lower activation of circulating platelets after implantation of Toyobo LVAS was associated with lower incidence of thromboembolism: a comparison with Novacor LVAS
Murasaki K.	-	Lower activation of circulating platelets after implantation of Toyobo LVAS was associated with lower incidence of thromboembolism: a comparison with Novacor LVAS
	-	HLA-DR and CD40 ligand expressing T-lymphocytes are increased in circulation in patients with idiopathic dilated cardiomyopathy
Murata M.	-	Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lanka ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X
Murciano J. C.	-	A novel platelet-specific delivery system for fibrinolytic agents
Murdoch D. L.	-	Population prevalence of atrial fibrillation and factors associated with use of warfarin
	-	Coagulation activation markers in atrial fibrillation: dose-dependent correlation with warfarin therapy
Murer E.	-	Reversal of ADP-induced aggregation in human heparinized plasma (HPRP), a model system for study of platelets which have been exposed to different degree of activation in vivo and means of modulating their response
Murphy C. V.	-	Thrombin causes an inflammatory cytokine response, which is inhibited by protein C, in both primary human monocytes and a monocyte (THP-1) cell line
	-	NovoSeven does not produce an inflammatory reponse in a monocyte (THP-1) cell line or primary monocytes prestimulated with lipopolysaccharide
Murphy S.	-	INTERCEPT platelets, treated to inactivate pathogens, maintain hemostasis in thrombocytopenic patients: results of the SPRINT trial
Murphy K.	-	Coagulation factor content of solvent/detergent plasma compared to fresh frozen plasma
Murphy T. J.	-	Terminal intron splicing of the prothrombin premRNA is associated with 3'-cleavage site recognition and polyadenylation
Murray P.	-	Safety and tolerability of argatroban anticoagulation in patients with end-stage renal disease undergoing hemodialysis: a prospective study
Murray E.	-	An evaluation of four methods of external quality assurance (EQA) for patient self-management (PSM) of oral anti-coagulation: report on 97 patients
Murray P.	-	A transient factor V inhibitor associated with vasculitis
Murugappan S.	-	Specificity and redundancy of G-protein pathways in agonist-induced alpha granule release in human platelets
Murugesan G.	-	High prevalence of aspirin resistance in patients with a history of myocardial infarction
Murugesan G.	-	Does cyclooxygenase-2 have a role in aspirin-dependent platelet function?
	-	Lysophosphatidylcholine induction of chemokines in human microvascular endothelial cells is dependent on the activation of MAP kinases and PI3 kinase
Murzilli S.	-	Effect of extra virgin olive oil on experimental thrombosis and primary haemostasis in rats
	-	Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
Musella L.	-	Antioxidant effect of wine in human: role of polyphenols
Mushunje A.	-	Measurement of the in-vitro half life and the pathological significance of the transition of anti-thrombin to the latent state
Mushunje A.	-	Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers
	-	In vitro and ex vivo study of the effects of core pentasaccharide and of longer heparin chains on latent antithrombin (AT)
Musial J.	-	Novel polymorphic short tandem repeat in the human a2 integrin gene promoter is associated with GPIa/IIa density on the platelet surface
	-	Factor V Leiden and blood coagulation at the site of microvascular injury in coumadin treated patients and healthy control
Musial J.	-	Cerivastatin neither inhibits thrombin generation nor decreases markers of inflamation in patients with APS
Musial J.	-	Prognostic value of selected genetic variants of platelet glycoprotein receptors in prediction of thrombotic events after percutaneous coronary interventions
	-	Factor VIII activity and blood coagulation in patients on long-term oral anticoagulation
Musilli N.	-	Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Mussa A.	-	Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies
Musso R.	-	Desmopressin subcutaneous administration enhances platelet response ‘in vivo’ to Platelet-Activating Factor (PAF) and causes a rise in interleukin-6 plasma levels in haemophilia A and von Willebrand disease type I
	-	The platelet glycoprotein IIb/IIIa receptor antagonist c7E3Fab inhibits the coagualation activation in patients undergoing to percutaneous transluminal coronary angioplasty (PCTA)
	-	Sickle cell disease, vascular endothelium dysfunction, abnormal endothelin-1 release, interleukin-6 plasma level, hyperhomocysteinaemia and thromboembolic risk
Mussoni L.	-	Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats
Muszbek L.	-	Thrombin-blood coagulation factor XIII interaction: in silico experiments
	-	Factor XIII subunit B: a protein A binding protein
Muszbek L.	-	Activation of factor XIII in whole plasma: the influence of Val34Leu polymorphism
Muszbek L.	-	Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
	-	Plasma factor XIII activity, concentration and FXIII-A Val34Leu polymorphism in patients with myocardial infarction and/or coronary sclerosis
	-	A novel mutation (1668delC) in the glycoprotein IIb (CD41) gene causing Glanzmann's thrombasthenia
Mutch N. J.	-	TAFI is cross-linked by its activation peptide to sites on fibrin(ogen) distinct from other inhibitors of fibrinolysis
Mutch N. J.	-	The C-terminus of a ₂-anti-plasmin: effect on fibrinolysis
Mutch N. J.	-	The role of TAFIa in relation to serpin inhibitors of fibrinolysis
Muto Y.	-	EF6265: a new synthetic, potent and selective plasma CPB/TAFIa inhibitor
Muysers C.	-	Safety and efficacy of Fibrogammin P^® for the treatment of patients with severe FXIII deficiency
	-	Treatment of patients with VWD requiring elective surgery with a pasteurized von Willebrand Factor/FVIII concentrate (Haemate^®P) – the use of a PK-guided approach
	-	Determination of High-Molecular-Weight von Willebrand factor multimers and their impact on specific VWF-activities in VWF/FVIII-concentrates
	-	Comparison of von Willebrand factor activities measured by ristocetin cofactor assay and two different VWF-collagen-binding-assays in VWF/FVIII-concentrates
Myles T.	-	Activated TAFIa down-regulates the pro-inflammatory activity of thrombin cleaved osteopontin
Myles T.	-	Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation: competition for cofactor sites on thrombin determines its fate
	-	Factor XI-activation by thrombin on activated platelets requires both anion binding exosites I and II
	-	Role of surface amino acid residues in thrombin essential for inhibition by antithrombin, heparin cofactor II and protein C inhibitor
Mysliwiec M.	-	Interaction between oxidative stress and chemokines in hemodialyzed patients
	-	Effects of different heparins on thrombin-activatable fibrinolysis Inhibitor-TAFI in hemodialyzed patients
	-	Induction of serum hepatocyte growth factor/activin/follistatin system during enoxaparin-anti-coagulated hemodialysis
	-	Relation between circulating endothelial markers and anti-coagulation with different heparins in hemodialysis patients: a prospective study
	-	Different pattern of hemostatic abnormalities in infectious and noninfectious systemic inflammatory response syndrome (SIRS)
	-	A prospective analysis of hemostasis in systemic inflammatory response syndrome (SIRS) with acute renal failure
	-	Soluble CD-146 and other markers of endothelial function are elevated in peritoneally dialyzed and chronic renal failure patients